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ABSTRACT OF THE THESIS 
 
 
 
 
DETERMINATION OF THE EXTRAVASCULAR BURDEN OF CARBON 
MONOXIDE (CO) ON HUMAN HEART 
 
 
Noninvasive measurements of myocardial carboxymyoglobin levels (%MbCO) and 
oxygen tensions (PtO2) are difficult to obtain experimentally. We have developed a 
compartmental model which allows prediction of myocardial %MbCO levels and PtO2 
for varied carbon monoxide (CO) exposures. The cardiac compartment in the model 
consists of vascular subcompartments which contain two tissue subcompartments varying 
in capillary density. Mass-balance equations for oxygen (O2) and CO are applied for all 
compartments. Myocardial oxygen consumption and blood flow are quantified from 
predictive formulas based on heart rate. Model predictions are validated with 
experimental data at normoxia, hypoxia, exercise and hyperoxia. CO exposures of 
varying concentration and time (short-high, long-low), CO rebreathing during 100% O2, 
and exposure during exercise is simulated. Results of the simulations demonstrate that 
during CO exposures and subsequent therapies, the temporal changes of %MbCO in the 
heart differ from those of carboxyhemoglobin levels (%HbCO). Analysis of correlation 
between %HbCO, %MbCO and PtO2 was done to understand myocardial injury due to 
CO hypoxia. This thesis demonstrates that the model is able to anticipate the uptake and 
distribution of CO in the human myocardium and thus can be used to estimate the 
extravascular burden (MbCO, PtO2 ) of CO on the human heart. 
 
Key words: Myocardial Oxygen Tension, CO Hypoxia, Exercise, Tissue Oxygenation, Cardiac 
Muscle 
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CHAPTER 1 
Introduction 
 
Chapter 1 explains the importance of the need for developing a model for 
predicting the extravascular burden of CO on the human heart. The chapter gives a 
basic introduction to carbon monoxide (CO) toxicity, and details the sources of CO, 
reactions of CO with the heme pigments in the body and the effects of CO exposure 
on oxygen (O2) delivery to tissues. This chapter discusses the symptoms, effects and 
treatment strategies of CO poisoning cases. Finally, the chapter highlights the 
hypothesis made and goals to be achieved in the following thesis.  
 
1.1 Carbon Monoxide (CO) Toxicity  
Carbon Monoxide (CO) is a byproduct of incomplete combustion of carbon-
based fossil fuels. CO is generated in toxic amounts by internal-combustion engines, 
faulty fossil-fuel heating systems, fire accidents, and emissions from modern 
automobiles in poorly ventilated spaces. The body produces CO as a by-product of 
hemoglobin degradation, but the gas does not reach toxic concentrations in vivo 
unless it is inhaled from exogenous sources (like faulty heaters, indoor charcoal grills, 
cigarette smoke, swimming behind a motorboat or under a houseboat, etc.). Carbon    
monoxide, which is a colorless, tasteless and odorless gas, is often referred to as an 
invisible killer as it is difficult to detect. Exposure to CO concentrations exceeding 
permissible exposure levels (PEL) of 50 ppm over an average of 8 hrs (1, 2) is a 
significant environmental and occupational health concern. There are approximately 
4000 deaths per year occurring in United States due to CO poisoning (3, 4, and 5). 
CO exposures and poisonings occur more often during the fall and winter, when 
people are more likely to use gas furnaces, heaters and generators in their homes (4, 
6).  
CO produces tissue toxicity by impairing oxygen (O2) delivery to the tissues. 
CO is absorbed by the respiratory tract and diffuses through the alveolar-capillary 
membrane and enters the blood, following a path similar to that of O2. The rate of 
absorption of CO decreases when the partial pressures of CO in blood of the 
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pulmonary capillaries and the alveolar air reach a state of equilibrium. After being 
absorbed and diffusing through the respiratory tract, CO combines reversibly with the 
heme pigments of the body, namely: (i) Hemoglobin (Hb) present in blood (ii) 
Myoglobin (Mb) present in muscle tissues, and (iii) other membrane bound heme-
containing compounds (e.g., cytochromes). Hemoglobin (Hb) is a tetrameric heme 
protein present in red blood cells whose main function is oxygen (O2) transport 
(Figure 1.1.1). O2 is stored in the lungs as a gas and in the blood. In the blood it is 
present in two (7) forms: (i) dissolved in plasma (normally 1.5% or 3 ml in 1 liter 
blood) and (ii) reversibly combined with hemoglobin (normally 98.5% or 197 ml in 1 
liter blood). Each hemoglobin molecule can bind to four oxygen molecules forming 
fully-saturated oxyhemoglobin (O2Hb), (Figure 1.1.2). Hb binds CO ~220 times more 
strongly than it binds O2, to form carboxyhemoglobin (HbCO) (Figure 1.3.1). 
Myoglobin (Mb) is a monomeric heme protein present in muscle tissue 
(Figure 1.2.2) and each myoglobin molecule can bind to one oxygen molecule 
forming oxymyoglobin (O2Mb) (Figure 1.2.1).  It is an oxygen store and also binds to 
CO to form carboxymyoglobin (MbCO) (Figure 1.2.3). Mb binds CO ~36 times more 
strongly than it binds O2.  
Thus CO toxicity causes mortality primarily due to the effects of severe 
hypoxia by attaching itself to Hb and Mb and reducing the oxygen carrying capacity 
of these heme proteins. CO usually replaces only two of the four O2 molecules bound 
to the heme groups of hemoglobin. In cases of high CO concentrations it is possible 
that CO may replace the third O2 molecule by binding to the third heme group (Figure 
1.3.2). Thus CO toxic hypoxemia causes changes in the circulatory, respiratory and 
metabolic demands of the tissue (8-18).  
Groups especially susceptible to the hypoxic stress of carbon monoxide 
exposure would potentially be individuals with cardiovascular and obstructive lung 
diseases, individuals with cerebrovascular and peripheral vascular diseases, and 
individuals with anemia. In addition, hospitalized individuals suffering from tissue 
hypoxia (e.g. shock) or those undergoing operations may be at increased risk. 
Individuals with undetected or undiagnosed coronary artery disease as well as the 
fetus, the newborn or, even pregnant women may be assumed to be at increased risk 
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because of the anticipated reduced capacity to accommodate hypoxic stress or some 
inherent sensitivity to hypoxia.  Furthermore, other populations such as those living at 
high altitudes, young children, or older adults may also be at increased risk (2).   
 
1.2 Symptoms, Diagnosis and Treatments of CO Poisoning  
 Symptoms and effects of CO poisoning are greatly dependent on the 
concentration and duration of exposure. CO poisoning could be acute (exposure to 
CO occurs and lasts no longer than 24 hrs) or chronic (exposure to CO that occurs 
more than once and lasts longer than 24 hrs). Generally, chronic exposures involve 
lower HbCO saturations due to lower CO exposures. Diagnosis of CO poisoning is 
difficult unless the event of toxicity occurs at site of high CO concentration like a 
house on fire or a blast in a coal mine. CO poisoning can be difficult to diagnose 
because CO poisoning symptoms are similar to those of flu. Specific information 
regarding the CO exposure duration and the concentration of CO inhaled is often 
unavailable. In addition valid blood HbCO level measurements are readily obtained 
but are an unreliable predictor of injury, and there are no clinical tests that can 
determine the extra vascular burden of CO (e.g., a noninvasive measurement of 
MbCO levels or tissue PO2 in humans). Although CO poisoning does not cause a 
fever, other symptoms are similar to those of the flu (including nausea, severe 
headache, vomiting) and also include neurological sequellae (memory loss, 
personality and behavior changes, brain damage etc), cardiac abnormalities in ECG, 
abnormal ventricular function and elevated cardiac biomarkers diagnostic of 
myocardial injury depending on the type of CO exposure. Treatment for CO poisoned 
victims involves administering supplemental O2. The treatment is with either 
normobaric hyperoxia, where 100% Oxygen (O2) is administered if the victim is 
conscious and HbCO levels in the blood are less than 25%,  or hyperbaric hyperoxia 
where 100% Oxygen (O2) is administered, at 1-3 ATA (1 atmosphere = 760 mm of 
Hg) pressure, if the victim is unconscious or the HbCO level exceeds 25%. However, 
there are some problems with the treatment strategies for CO poisoning victims.  
Decision of the treatment protocol is based on the measured HbCO levels in the 
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venous blood. Blood %HbCO is readily measurable but is thought to be an unreliable 
measure of poisoning severity. Carboxymyoglobin (MbCO) levels and tissue partial 
pressures of oxygen (PO2) which are more reliable indicators of CO toxicity in the 
tissue are difficult to measure through any clinical procedures. Treatment strategy is 
often debatable and it may not be very clear whether hyperbaric hyperoxia rather than 
normobaric hyperoxia treatment is necessary (19, 20, 21, 22, 23). Despite treatment 
after CO poisoning, neurological and cardiac sequellae often occur. 
 
1.3 Motivation for the Thesis  
CO hypoxia results in impaired O2 delivery causing a decrease in O2 uptake by 
the cells. This diminished O2 utilization causes alterations in biochemical (cardiac 
troponin I, phosphocreatine (PCr), lactate) and physiological (cardiac output, rate 
pressure product, metabolic rate) activities. Elevated cardiac biomarkers (cardiac 
troponin I ≥ 0.7ng/ml, CK-MB (Creatine kinase MB isoenzyme)  mass ≥5.0ng/ml) 
and diagnostic EKG (electrocardiogram) changes (like ST segment elevation, T- 
wave changes), abnormal left ventricular (LV) function (like alternations in left 
ventricular ejection fractions) and regional wall motion abnormality are observed in 
moderate to severely CO poisoned patients (24). In a population of 230 CO poisoned 
patients, 44% of deaths were reported to be due to cardiovascular causes such as 
cardiac arrest, myocardial infarction, congestive heart failure, fatal arrhythmia (24).   
Also, there is evidence that workers who are exposed to high CO concentrations 
have an increased risk for cardiovascular morbidity and mortality (25, 26). The effect 
of high CO exposures would pose a greater risk for injury during exercise, as there 
would be increased demand for O2 in the tissue accompanied with O2 impairment due 
to CO binding to hemoglobin and myoglobin. Exercise also increases ventilation 
which, in turn, increases the amount of CO inhaled and thus the dose of CO. 
Coronary circulation is very sensitive to O2 deprivation as the myocardium has 
a very high O2 extraction fraction (Measure of quantity of O2delivered to the tissue 
and is defined as ratio of arterial and venous (A- V) O2 concentration difference and 
arterial (A) O2 concentration) to   causing profound effects of CO in the myocardium. 
Each molecule of myoglobin in the heart is capable of binding to one CO molecule by 
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means of the heme group to form carboxymyoglobin (MbCO), which would further 
increase the CO content in the heart tissue causing a decrease in O2 availability. Also, 
the contribution of myoglobin diffusion during CO hypoxia is unclear (27, 28, 29). 
All the above recent reports on cardiac impairment, occurring with CO poisoning 
motivated scientists to understand the causes of cardiovascular abnormalities in CO 
poisoning victims (30, 31, 32). Therefore, keeping these facts in mind, the following 
hypothesis was made for the thesis: 
 
Hypothesis: “During CO exposures and subsequent therapies, the temporal changes 
of %MbCO in the heart differ from those of %HbCO; in particular, there are times 
during the therapy %MbCO can sometimes increase when %HbCO is decreasing”.  
 
The importance of this hypothesis is that CO load delivered to the heart impairs 
oxygen delivery, further affecting the tissue oxygen tension (PtO2) and O2 pressure 
gradients.  This CO load is related to both %HbCO in arterial blood perfusing the 
heart and %MbCO in cardiac tissue.  If %MbCO and %HbCO change in opposite 
directions, then the currently-used clinical indicator of potential injury (i. e., %HbCO) 
will be inaccurate and possibly misleading.  Thus, determining the total CO load on 
the cardiac cells (or its effect on tissue PO2) might be a better predictor of injury. 
 
1.4 The Need for our Model  
Determination of the burden of CO (vascular - %HbCO and extra vascular - 
%MbCO) and its effects on tissue PO2 during uptake and washout would provide a 
better assessment of risk associated with a range of exposure conditions in CO 
toxicology. This specific task can be accomplished in two ways:  
1. Conduct experiments involving CO exposures 
2. Estimate CO burden from a “Mathematical Model” 
Conducting experiments involving low CO exposures can be accomplished in 
human subjects, but it would be unethical to expose subjects to high CO exposures to 
understand causes of injury due to CO and predict clinical outcomes. Also, these 
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experiments are difficult to conduct and require detailed care, great expertise and are 
also expensive. Even if these experiments are conducted, non-invasive measurements 
of MbCO are not possible. Also, invasive or non-invasive reliable measurements of 
tissue oxygenation in healthy human hearts are difficult to make. Experimental 
measurements of human myocardial O2 tension have been reported in patient 
populations with cardiovascular abnormalities (33, 34). Thus, the best option would 
be to build a model to predict the burden (vascular-HbCO; extra vascular- MbCO) of 
CO on the human heart by doing simulations for a range of CO exposures.  If one can 
implement O2 interaction equations, the model can also help to predict oxygen 
tension in the heart. Further, the model can be used to anticipate levels of CO that 
may be lethal to the heart or to assess the risk of cardiac injury when exercise is 
accompanied with CO exposure. This information would be helpful to design 
treatment protocols for people exposed to CO while at work. Thus the approach I 
decided to take to test the hypothesis is as follows: 
Approach: “Since O2 and CO levels in heart are not measurable non-invasively in 
humans, a plan to estimate these values from a model was made.”  
After formulating a hypothesis, the next task was to assess the literature for the 
availability of an appropriate model for predicting uptake and washout of CO. After 
making a diligent search, the model developed in our lab by the authors of                    
reference 35 seemed most suitable. The process from setting an objective to reaching 
a solution is summarized in Figure 1.4. 
The reasons for selecting this model are explained in detail in section 2.1 of chapter 2. 
This model consisted of lumped compartments for lungs, blood (arterial and venous), 
skeletal tissue and non-muscle tissue. Mass balance equations for CO were used to 
represent the compartments (35). However, this model also had some limitations and 
so the model was further modified in our lab resulting in a better and more efficient 
model (Bruce, Bruce, and Erupaka, in preparation) which, however, was still 
inadequate for the present purposes because it did not include a compartment for the 
heart. Figure 1.5 shows the different stages of model development. Thus, the next 
task was to accomplish the following goals of the thesis to test the hypothesis made. 
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The major goals of the thesis are:  
(1) Introduce a two compartment cardiac block into the model.  
(2) Implement mass balance equations for O2 and CO. 
(3) Test and validate the model with experimental data for conditions of rest, 
exercise, CO exposure and hypoxic hypoxia and hyperoxia.  
(4) Use the developed and validated model to predict extravascular burden of 
CO and O2 tension in the cardiac tissue during short-high concentration 
CO exposures, CO rebreathing studies in 100% O2, long-low 
concentration CO exposure, exercise in the absence and presence of CO, 
and to determine CO concentrations injurious to the heart. 
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Figure 1.1: Hemoglobin (Hb) and Oxyhemoglobin (HbO2). Hemoglobin (Figure 
1.1.1) is a tetrameric heme protein present in red blood cells. O2 binds to the heme 
(Fe) protein present in hemoglobin to form oxyhemoglobin (Figure 1.1.2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure1.1.1    Hemoglobin              Figure 1.1.2     Oxyhemoglobin 
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Figure 1.2: Oxymyoglobin (MbO2), Myoglobin (Mb), Carboxymyoglobin 
(MbCO). Myoglobin  (Figure 1.2.2) is a monomeric heme protein present in muscle 
tissue. O2 binds to the heme (Fe) protein present in myoglobin to form oxymyoglobin 
(Figure 1.2.2).CO also binds to the heme protein to form carboxymyoglobin (Figure 
1.2.3 ) 
 
 
 
 
 
 
 
 
 
 
 
Figure1.2.1                 Figure 1.2.2                          Figure 1.2.3                  
Oxymyoglobin                   Myoglobin                     Carboxymyoglobin  
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Figure 1.3:  Carboxyhemoglobin (MbCO). CO binds to the heme (Fe) protein 
present in hemoglobin to form carboxyhemoglobin. 
 
 
 
 
 
 
 
 
 
 
 
Figure1.3.1   Carboxyhemoglobin      Figure 1.3.2    Carboxyhemoglobin 
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Figure 1.4: Overview of the Thesis 
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Figure 1.5: Stages of Model Development 
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CHAPTER 2 
Background 
 
Chapter 2 provides information on models present in the scientific literature that 
predict CO uptake and the limitations of these models. This chapter discusses the 
basis for selecting a specific model for the thesis from the models present in the 
literature and the necessity to modify the selected model to test the hypothesis made. 
This chapter also gives a basic introduction to the concepts, simulation software used 
and an overview of all the compartments present in the model. As it is difficult to 
measure (non-invasively) carboxymyoglobin levels (MbCO) and tissue O2 tension 
(PtO2) in the human heart, building a model for estimating these parameters seemed 
the best approach. Modification may include implementing desired features to cater to 
the needs of the desired model and to overcome the limitations of the available 
models. 
  
2.1 Previous Models  
The CFK (Coburn Forster Kane) model often discussed in the carbon monoxide 
level (CO) literature predicts carboxyhemoglobin (COHb) levels for acute and 
chronic CO exposures (Coburn et al. 1965). The CFK equation establishes a relation 
between the blood COHb levels, rate of endogenous CO production, and CO 
exchange rate due to respiration. However, this model has certain limitations.  For 
example, the model lumps the total blood volume into a single homogeneous, well 
mixed compartment and also excludes the dissolved CO or oxygen (O2) in the blood 
while determining the COHb levels in the blood. The CFK model analytically solves 
the linearized CFK equation by assuming a constant O2Hb concentration in the blood.  
The model predictions agree well with experimental values under normal 
conditions but disagree with experimental values involving transient CO exposures 
(154), involving fast reactions of CO with Hb (Forster (1970), Holland (1970), 
Roughton (1964), Waller et.al (1988)). Later Peterson & Stewart (1975), Bernad & 
Duker (1981), Tyuma et. al (1981) and Collier & Goldsmith (1983) solved the CFK 
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equation by accounting for the variation of O2Hb using iterative methods, analytical 
solutions etc.  
More recently, a mathematical model was developed (36) to predict alveolar 
partial pressure of CO and blood HbCO as a function of exposure time and CO 
concentration. CO uptake by blood was predicted taking into account the diffusion 
based transport mechanisms of CO and the replacement reaction of CO with O2Hb. 
Benignus et al. (1995) developed a model to predict blood COHb levels considering 
variations in inhaled O2, CO2 and CO concentrations. But the drawback of these 
models was that they limited their CO uptake predictions to the vascular 
compartments. They did not include diffusion of gases from vascular compartments 
to the surrounding tissue. This results in exclusion of extravascular storage sites of 
CO like myoglobin present in muscle tissue and cytochrome oxidase in mitochondria. 
Also, the concept of lumping blood into one single compartment results in loss of 
physiological relevance related to variability in O2 concentrations (O2 content is 
greater at the arterial side compared to venous side) and partial pressures present in 
different blood subcompartments, which affects the predicted CO load.  
Bruce (2003) developed a model that predicted distribution of CO in the body 
by considering CO diffusion between the vascular and extravascular compartments. 
The model (Figure 2.1) had a lung compartment, blood (arterial and venous) 
compartments, muscle and non-muscle tissue with vascular and extravascular 
compartments. Herein this model will be referred to as the primary model in this 
thesis. Mass balance equations for CO were written for all the compartments of the 
model and are described in detail in (35).  An example of the mass balance equation 
for CO for the alveolar compartment from the above model is as follows: 
  )()]()([)(
.
tCOflux
P
VtCOPtCOP
dt
tCOdCV LB
B
A
Ai
A
L −−=  
where VL is lung volume, CACO is the alveolar CO concentration, PACO is the 
alveolar partial pressure of CO (PCO), PiCO is inhaled partial pressure of CO, t is 
time, and COfluxLB(t) is the CO flux from lungs to blood defined  as 
  CODdtCOPKtCOPKCOPtCOflux LvvvecvALB ))]()()1(([)( −+−−=  
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where PecCO is end-capillary PCO, dv  is the mean transport delay in mixed 
venous blood, PvCO is mixed venous partial pressure of CO, and Kv is used to 
apportion the effective pulmonary capillary PCO between the mixed venous and end-
capillary pressures. Vascular mixing in the pulmonary capillary compartment is 
ignored and CecCO is determined by adding COfluxLB to the mixed venous blood, 
which enters the lungs after the mean transport delay (dv) from venous blood 
compartments. 
 
In the modified model (discussed in Section of 3.2 of chapter 3) and final model 
(discussed in Section 3.3 of chapter 3) the same CO mass balance equations are used 
for the alveolar compartment (as shown above) and the non-muscle tissue. For the 
skeletal muscle (tissue and blood subcompartments), CO mass balance equations in 
the final model (model developed for thesis) are described for two tissue 
subcompartments and three blood vascular subcompartments, unlike equations used 
for the single blood vascular and tissue compartments discussed in (35).  
To determine the partial pressure of carbon monoxide (PCO) in each blood 
compartment of the primary model it was necessary to solve three simultaneous 
algebraic equations of O2 (discussed in Reference 35): 
 
1. Oxyhemoglobin Dissociation Curve (ODC). 
2. Haldane’s  Equation. 
3. Blood to Tissue Oxygen Flux Equations. 
 
2.1.1 Oxyhemoglobin Dissociation Curve 
The oxyhemoglobin dissociation curve gives the saturation of oxygen as a 
function of the partial pressure of oxygen. There are number of factors that affect the 
binding of oxygen to hemoglobin which change the shape of the curve.  Factors that 
affect the ODC are variation of the hydrogen ion concentration (pH), effects of 
carbon dioxide, effects of 2,3-DPG (2,3-Diphosphoglycerate), temperature, carbon 
monoxide, effects of methemoglobinemia (a form of abnormal hemoglobin) and fetal 
hemoglobin (37). ODC is shifted to the right by an increase in temperature, 2, 3-DPG, 
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or PCO2, or a decrease in pH. In this model, for the conditions that the authors intend 
to simulate the most important factor that may affect the curve is the carbon 
monoxide level. In the absence of CO, the sigmoidal shaped curve approaches a 
horizontal asymptote as the partial pressure of oxygen exceeds approximately 70 
mmHg and declines with a steep slope toward a point of inflexion when the partial 
pressure of oxygen falls approximately below 60 mmHg. Carbon monoxide also has 
the effect of shifting the curve to the left. Thus, a set of equations were derived to 
represent the O2 dissociation relationship in the presence of CO by determining the 
dependence of the Hill parameters on the HbCO level and then applying a correction 
to the Hill equation at low O2 pressures. The method for the derivation is detailed in 
the paper (35). When the inspired CO levels are zero, the ODC retains its shape. 
Except at low PO2 values, a reasonable approximation to this curve for any given 
level of HbCO is the Hill equation given below 
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Where ( )[ ] 1%exp1 2150 −⋅+= COHbapapP            and  
)%025.0exp(21 COHbanann ⋅−⋅+=  
ap1,ap2,an1, an2 are constants resulting from curve fitting for various 
concentrations of CO. P50 is the PO2 necessary to half-saturate the Hb.  
 
The ODC for Mb (Figure 5 of reference 38) is also represented by a Hill 
equation, but it is assumed that its parameters are independent of the 
carboxymyoglobin (MbCO) level except for that of the maximum O2-binding 
capacity.  At each time step of the simulation, the dissociation curve for Mb and the 
Haldane equation for Mb are satisfied simultaneously via an implicit solution using an 
iterative procedure. 
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The Hill equation for myoglobin is 
 
    
][1
][
2
502
2 MbO
PMbOPO −
⋅= . 
 
 where PO2 is the oxygen tension and [O2Mb] is the fractional O2 saturation of 
myoglobin. P50 is the PO2 at which myoglobin is half-saturated with oxygen and is 
dependent on temperature and pH. 
 
2.1.2 Haldane’s Equation 
PCO was determined by first solving for the other variables, assuming that PCO 
is constant across an integration step, and then updating its value via the Haldane 
equation as shown below. 
                                      
HbO
P
COHb
PM OCOHb
2
2=  
 
MHb is the Haldane affinity ratio for hemoglobin and has a value of 218. The 
volumetric carrying capacity of Hb for O2 or CO is calculated as the product of Hb 
concentration and the nominal maximum O2 content, 1.38 ml O2/g Hb. The Haldane 
equation for myoglobin is  
 
    
MbO
PO
COMb
PM COMb
2
2=  
 
 MMb is the Haldane affinity ratio for myoglobin and has a value of 36. At each 
time step of the simulation, the dissociation curve for Mb and the Haldane equation 
for Mb were satisfied simultaneously via an implicit solution using an iterative 
procedure.  
 
2.1.3 Blood to Tissue Oxygen Flux Equations 
The blood to tissue oxygen flux equations are described in (35).  It was assumed 
that O2 diffuses from the vascular to the extravascular subcompartments of the tissues 
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at rates just sufficient to meet the metabolic demand of the tissue. Endogenous CO 
production was included by assuming that all endogenous CO is delivered to the 
mixed venous compartment.  
  
2.2 Chosen Model and Proposed Modifications 
The model (primary model) developed by Bruce (2003) fit the criteria of the 
model needed for the thesis as the model accounted for transport of CO in the 
pulmonary compartment, CO bound to Hb and dissolved in plasma, and transport of 
CO from the blood flow to surrounding tissue. This model consists of five major 
compartments: 1.The arterial blood, 2. The Lungs, 3. Skeletal Muscle, 4. Non-muscle  
tissue and 5. Mixed venous blood compartments (Figure 2.1). Herein this model will 
be referred to as the primary model in this thesis. However, O2 parameters were 
assumed to be constant in this model and were passed as arguments. 
Thus the primary model was chosen and certain modifications were proposed to 
test the hypothesis made. The proposed modifications are as follows: 
Tissue O2 tension which is an important predictor of the oxygenation state of the 
tissue can also be anticipated by adding equations for O2 mass balances. This would 
also aid in accounting for the nonlinearities in an efficient way.  
The model predictions would be more physiologically relevant if the single 
muscle compartment was divided into subcompartments. This would allow diffusion 
of gases within the tissue resulting in better solution estimates for O2 tensions and CO 
load. Therefore, in our lab we intended to replace the single lumped muscle 
compartment with two subcompartments. Regional heterogeneity of blood flow and 
O2 consumption in skeletal muscle demanded development of predictive equations to 
calculate the arm, the trunk and the leg skeletal mass distributions. Also, a formula 
was developed to predict an increase in cardiac output with increased COHb level in 
blood. A paper on the updated model is in preparation (Bruce, Bruce, and Erupaka). 
Though heart is a muscle tissue, it has a different morphology from skeletal 
muscle tissue. Cardiac muscle has a different capillary density (39), resting blood 
flow (Table 2.1) and metabolic rate (Table 2.2) from that of skeletal muscle (Table 
2.3 and Table 2.4). Lumping the skeletal muscle and cardiac muscle into a single 
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compartment would not be a good assumption to make.  Thus, it would be important 
to add a heart compartment to the model in order to model CO uptake and PO2 in the 
myocardium and relate them to cardiac injury.  
Another objective was to develop better and more efficient algorithms to 
determine PO2 and PCO in the compartments. The algorithms used in the primary 
model had convergence issues while solving the O2 dissociation curves of Hb and Mb 
(especially solving for PO2 and PCO when certain conditions caused ODC to be flat)  
and resulted in numerical errors. It was also important to modify the blood to tissue 
oxygen flux equations by evaluating them as a function of pressure gradients and 
diffusion coefficients of O2 instead of making an assumption of equality between O2 
flux and metabolic demand of the compartment. 
 
2.3 Basic Concepts of the Model  
The basic concept used in developing the model is the continuum theory of 
conservation of mass. Figure 2.2 gives a summary of basic concepts needed to build a 
model. Mass balance equations are written for CO and O2 for all compartments. Mass 
balance equations state that for any substance Q in a compartment, 
 n)destructio of rate outflow of (rate–  creation) of rateinflow of rate(/ ++=dtdQ  
The model diagram and dynamic equations are described in detail in chapter 3. 
The simulation tool or software used to apply principles of physiology and 
engineering to a model is ACSL (Advanced Continuous Simulation Language). This 
tool has been exclusively developed for the purpose of modeling systems described 
by time dependent, non-linear differential equations or transfer functions. ACSL 
application areas include control system design, missile and aircraft simulation, 
power plant dynamics, biomedical systems, vehicle handling, heat transfer analysis, 
etc.  Most of its basic elements are defined from FORTRAN, however the latest 
version is a fusion of various other languages like C++, JAVA, etc., which supports 
enhanced graphical user interface (GUI) and displays. The algorithm used for 
integration is the Runge-Kutta-Fehlberg algorithm with fixed order and variable step. 
The algorithm evaluates the derivative three times per step and makes a second order 
advance. If any error in a state is larger than that allowed, the step size is reduced 
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until the error criteria are satisfied for all the states. Apart from the integration 
algorithm which is built-in in ACSL, other algorithms are developed as macros and 
called to solve certain simultaneous algebraic equations which are discussed in 
section 3.8 of chapter 3.  
In general models have several parameters to be estimated and the values for 
these parameters are either taken from the literature available or they are estimated. 
When available, subject-specific values of model parameters were obtained from the 
literature or directly from the investigators. Usually, the age, weight, and height of a 
subject were available, and often one or more additional parameters, such as Hb 
concentration, total blood volume, cardiac output (Q˙), or ventilation, were provided 
by the investigators. In some cases, average values for a group of subjects were used. 
Predictive formulas were used to estimate Q˙ (when it was not measured) and tissue 
volume of skeletal muscle ( mV ) as functions of body weight (BW), age (A), height 
(HT), and gender (G; has a value of 1 for a male and 0 for a female subject). 
Predictive formulas were used from published papers, 
 
  GBWG 2001400)9.71.54(Q −++=⋅  (40) 
Cardiac output was calculated in ml/min 
 
  04.1/)3.3098.06.680.7244.0(1000 −−++= AGHTBWVm  (41) 
Tissue volume of skeletal muscle was calculated in ml. 
 
2.4 Anatomy of the Heart 
The heart is the mechanical pump that circulates blood through the blood 
vessels involuntarily maintaining the homeostasis of blood to tissue exchange.  The 
heart has several surfaces (anterior, inferior) and membranes that surround and 
protect the heart without interrupting the contraction and vigorous movement of heart. 
The heart wall consists of three layers namely the epicardium which is the external 
layer, the myocardium which is the middle layer of the wall and the endocardium, the 
inner layer of the heart wall.  The myocardium is an involuntary cardiac muscle tissue 
which makes up the bulk of the heart and is responsible for the pumping action of the 
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heart. There exists oxygen supply and consumption heterogeneity in theses layers of 
the heart wall corresponding to variable oxygen tensions (Table 2.5).                        
 The heart has four chambers. The right and left atria which receive blood from the 
great veins (superior vena cava, inferior vena cava, coronary sinus) and from the 
lungs through the pulmonary veins, respectively. The right and left ventricles perform 
the pumping action of blood. However, these chambers also vary in thickness 
according to their function. The left ventricle pumps blood to vasculature at greater 
distances with large blood flow resistance resulting in higher pressures compared to 
the right ventricle. Thus the left ventricle has a thicker wall as it works harder. The 
left heart is generally considered the energy source of the system. The greater work 
load in the left ventricle results in higher blood flow through the cardiac muscle and 
greater oxygen consumption compared to other chambers of the heart, as the tissues 
match their vascular function to their metabolic needs. During resting conditions, the 
myocardial oxygen extraction fraction is 60-70% (42). 
 
 It is a known fact that the heart requires energy to maintain ionic balance and 
synchronous contractions. This energy is supplied by the ATP (Adenosine Tri 
Phosphate), which needs oxygen for aerobic metabolism to take place. In cases of 
increased myocardial stress, conditions of hypoxia, hypoxemia or CO poisoning, the 
energy metabolism cycles are disrupted (43-47) and an increase in coronary supply 
should occur to prevent tissue hypoxia. Thus, modeling O2 delivery and demand is 
needed to estimate the burden of hypoxia on the cardiac tissue. As CO impairs 
oxygen delivery, causing discrepancies in the tissue-blood PO2 gradients, the 
objective was to develop a model to estimate the oxygen tension in the cardiac tissue 
and also predict the burden of the CO load delivered to the heart. 
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Table 2.1: Myocardial Blood Flow 
 
 
(Table also referred in Section 3.4) 
 
 
 
 
 
 
 
Species Condition Region Value (ml/min/g) Technique Reference 
Baboons Awake, Sitting Left ventricle 
2.41 ±   
0.90  
ml/min/g 
(80%) 
15 um Microspheres 55 
  Right ventricle 
1.74 ± 0.73 
ml/min/g 
(16%) 
  
Dogs Sedated - Responsive 
Left 
ventricle 
0.96 ± 0.11 
ml/min/g Microspheres 56 
  Right ventricle 
0.77 ± 0.07 
ml/min/g   
  
Interventri
cular 
septum 
0.91 ± 0.10 
ml/min/g   
Dogs Anesthetized Left ventricle 
1.14 ± 0.38 
ml/min/g Microspheres 57 
  Right ventricle 
0.72 ± 0.28 
ml/min/g   
Dogs anesthetized Left ventricle 
0.86 
ml/min/g Microspheres 58 
  Right ventricle 
0.48 
ml/min/g   
Dog-
closed 
chest 
anesthetized Left ventricle 
1.0 
ml/min/g Microspheres 59 
Humans 
25 ± 3 yr 
[LV=196 ± 38 
g] 
Left 
ventricle 
0.79 
ml/min/g PET - semi-supine 60 
Humans 
46±12 yr 
[LV=193 ± 20 
g] 
Left 
ventricle 
0.88 ± 0.19 
ml/min/g PET 61 
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Table 2.2:  Myocardial Oxygen Consumption  
 
 
 
(Table also referred in Section 3.4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Species Region Value (ml/min/100g) Technique Reference 
Awake Dog Right ventricle 4.7 ± 0.5 BNII nephelometer 51 
Dog Right atrium 4 ,, 52 
Dog Left ventricle 8.6 ,, 52 
Dog Left atrium 0.8 ,, 52 
Dog Whole heart 8.2 ± 2.1 PET 53 
Dog Whole heart 7.0 ± 1.5 PET  
Dog Left ventricle 8.8 ± 1.5 PET 54  
Human Heart 8.2+/-2.1 ml/min/100g 11C-acetate and PET 53 
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Table 2.3: Skeletal Muscle Blood Flow 
 
Values( 
ml/min/100ml tissue) Species Region       Method Reference 
1.4±0.6 Human Gastrocnemius 133Xe clearance technique 62 
1.6±0.4 Human Brachioradialis 133Xe clearance technique " 
1.8±0.7 Human Flexor digitorum superficialis 
133Xe clearance 
technique " 
1.5±0.6 Human Biceps 133Xe clearance technique " 
1.6±0.4 Human Triceps 133Xe clearance technique " 
1.4±0.6 Human Tibialis 133Xe clearance technique " 
1.6±0.6 Human Quadriceps 133Xe clearance technique " 
2± 0.5 Human Leg proximal  auto radiographic  50 
 25 
Table 2.3 Skeletal Muscle Blood Flow (Continued) 
Values( 
ml/min/100ml tissue) Species Region       Method Reference 
1.8±0.7 Human Forearm extensor 
strain gauge 
plethysmography and 
133Xe clearance 
technique 
" 
2.7±0.3 Human Forearm strain gauge plethysmography " 
3±0.7 Human Calf strain gauge plethysmography " 
3.8±0.4 Human Forearm 
venous occlusion 
plethysmography and 
mercury-in-silastic 
strain gauges 
" 
2.1± 1.1 Human Calf - extensors (15)) H20 PET 67 
2.1± 1.1 Human Calf - flexors " " 
Table 2.3 Skeletal Muscle Blood Flow (Continued) 
Values( 
ml/min/100ml tissue) Species Region       Method Reference 
3.1±1.7 Human Muscle emission tomography and 15 O labelled water 63 
1.9± 0.5 Human Leg proximal  auto radiographic method 50 
1.9± 0.5 Human Leg middle auto radiographic method " 
1.6± 0.4 Human Leg distal  auto radiographic method " 
1.4± 0.3 Human Leg distal  auto radiographic method  
1.4± 0.64 Human Brachiradialis NIRS technique after venous occlusion 49 
0.81± 0.47 Human Flexor digitorum superficialis NIRS  IO50 64 
0.72± 0.32 Human Flexor digitorum superficialis NIRS  IO36 " 
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(Table also referred in Section 3.1, Section 3.2.2) 
 
 
Table 2.3 Skeletal Muscle Blood Flow (Continued) 
 
 
 
 
 
Values( 
ml/min/100ml tissue) 
 
 
 
 
 
 
Species 
 
 
 
 
 
 
Region 
 
 
 
 
 
 
      Method 
 
 
 
 
 
 
Reference 
1.42± 1.04 Human Brachioradialis Fick/plethysmography  64 
2.06± 0.7 Human Forearm " " 
2.6± 1.2 Human Calf-profound flexors " " 
3.1± 0.27 Human Forearm 
venous occlusion and 
strain gauge 
plethysmography 
65 
3.12±1.55 Human Femoral (15O)H2O and PET " 
3±2 Human Skeletal muscle (15O)H2O,(15O)CO and PET 66 
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Table 2.4: Skeletal Muscle Oxygen Consumption 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Table also referred in Section 3.2, Section 3.2.2) 
 
 
Species Region MRO2 Value(ml/min/100g) Technique Reference 
Human Forearm 0.15 ± 0.01 NIRS -arterial occlusion 48 
Human Forearm 0.114  ±  0.03 
NIRS -venous 
occlusion 49 
Human Quadriceps femoris 0.21  ±  0.04 PET 50 
Human Quadriceps femoris 
0.21  ±  0.03 
mid PET 50 
Human Quadriceps femoris 
0.17  ±  0.02 
most distal PET 50 
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Table 2.5:   Myocardial Tissue Oxygen Tension in Various Species 
 
 
 
 
Species 
 
 
 
 
 
Region 
 
 
 
 
Mean PO2 
Value 
 
 
 
Arterial 
PO2 
 
 
 
Method 
 
 
 
Reference 
 
 
Mice(N=5) 
 
Left ventricle 
mid-myocardium 
 
Mean PO2 = 
~15.5 mm Hg 
 
  OxySpin - EPR 
 
145 
 
 
Cat(N=6) 
Surface of 
beating heart  
(histogram) (~ 5 
- 60 Torr) 
 
Median PO2 = 
31 mm Hg 
 
"Steady state" 
(normoxia) 
 
Platinum 
electrode 8 mm 
146 
 
 
Cat(N=6) 
Surface of 
beating heart  
(histogram) (~ 5 
- 125 Torr) 
 
 
42 mm Hg 
 
 
464.7 mm Hg 
 
Platinum 
electrode 8 mm 
146 
 
 
Cat(N=6) 
Surface of 
beating heart 
(histogram) ( ~ 
10 - 115 Torr) 
 
 
35 mm Hg 
 
 
259.3 mm Hg 
 
Platinum 
electrode 8 mm 
146 
 
 
Cat(N=6) 
Surface of 
beating heart 
(histogram) ( ~ 0 
- 15 Torr) 
 
4 mm Hg (79% 
= 0-5 Torr) 
 
18.7 mm Hg 
 
Platinum 
electrode 8 mm 
146 
 
 
Mouse (N=7) 
 
 
Mid-
myocardium 
 
 
 
16.4 ± 0.7 mm 
Hg 
 
 
(normoxia) 
 
LiPc crystals - 
EPR 
147 
 
 
Dog (N=24) 
 
 
Left ventricle  6 
mm deep 
 
 
42±7 mm Hg 
 
 
143 ± 23 
 
 
Paratrend probe 
 
 
147 
 
 
Dog (N=5) 
 
Anterior wall of 
left ventricle 
 
 
36±8 mm Hg 
 
 
 
Polarographic 
Clark type 
 
148 
 
 
Dog (N=12) 
Left epicardium 
(2 mm deep) 
"coronary 
stenosis" 
 
52±7 mm Hg 
 
Ventilated with 
100% O2 to 
maintain 
normocapnia 
 
Monopolar 
Polarographic 
needle 
 
149 
 
 
 
Dog (N=9) 
Left ventricular 
myocardium: 
shallow - before 
bypass 
 
 
17.1 mm Hg 
 
 
65 mm Hg 
 
 
Mass spec 
150 
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Table 2.5   Myocardial tissue Oxygen tension in various species (Continued) 
 
 
 
Species 
 
 
 
 
Region 
 
 
 
 
Mean PO2 
Value 
 
 
 
 
Arterial 
PO2 
 
 
 
Method 
 
 
 
Reference 
 
 
Dog (N=9) 
Left ventricular 
myocardium: 
deep - before 
bypass 
 
 
14.5 mm Hg 
 
 
65 mm Hg 
 
 
Mass spec 
150 
 
 
 
Dog (N=9) 
 
Left ventricular 
myocardium: 
shallow - after 
bypass 
 
 
28.3 mm Hg 
 
 
65 mm Hg 
 
 
Mass spec 
150 
 
 
Dog (N=12) 
 
Left ventricular 
myocardium: 3 
mm deep - 
subepicardium 
 
 
29.5 ± 2.5 mm 
Hg 
 
Coronary 
blood flow in 
LAD=29.7 ± 
3.9 ml/min 
 
 
 
polarography 
 
151 
 
 
Pig (N=13) 
 
Left ventricle 
(surface of 
epicardium) 
 
 
49 ± 2 mm Hg 
 
 
23 ± 1 mm Hg 
 
 
Clark-type 
electrodes 
 
151 
 
 
Human M 
38yr 
 
 
Right ventricular 
myocardium: 6 
mm deep 
 
 
39.73 mm Hg; 
(median=28) 
 
 
168-210 mm 
Hg 
 
 
Platinum needle 
electrode 
 
152 
 
 
Human M 
42yr 
 
 
Left ventricular 
myocardium:   6 
mm deep 
 
 
19.4 mm Hg; 
(median=17) 
 
 
78-126 mm Hg 
 
 
Platinum needle 
electrode 
 
 
152 
 
 
Human F 8yr 
 
 
Left ventricular 
myocardium:   6 
mm deep 
 
 
27.4 mm Hg; 
(median=24) 
 
 
48-51 
 
 
 
Platinum needle 
electrode 
 
 
152 
 
 
Human 
(N=13) 
 
Left ventricle - 
mid-myocardium 
 
 
42 mm Hg 
(n=15) 
 
 
93 to 470 mm 
Hg 
 
 
mass spec 
 
153 
 
 
 
Piglets 
 
 
Epicardial 
surface of left 
ventricle 
 
 
16.8 ± 4.2 mm 
Hg 
 
 
106 ± 5.5 on 
room air 
 
 
phosphorescent 
O2 
 
 
153 
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Figure 2.1: Primary Model. The model consists of five major compartments. Mass 
balance equations were written for CO. CO enters through the lungs and diffuses to 
the muscle tissue and non-muscle tissue compartments via the arterial blood 
compartment. CO then enters the venous blood compartments after a time delay. For 
the detailed figure refer to 35 
(Figure also referred in Section 3.1) 
 
 
 
CO enters through the lungs 
 
 
                 
CO is exhaled through the 
lungs 
Q•v 
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Continuum theory
of conservation of mass
Model Diagram  and Parameter Estimation
Dynamic Equations
Computer code
Software-
ACSL
Algorithms for solving 
dynamic equations
 
 
Figure 2.2: Basic Concepts of Building a Model. The basic concepts for building a 
model are determining the principle for the model (conservation of mass), sketching 
the model diagram, determining the parameters, and choosing suitable software to 
build the model. 
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CHAPTER 3 
Model Description 
 
Chapter 3 discusses a brief overview of the modifications to the primary model. 
The chapter explains the general form of the mass balance equations for O2 and CO 
for a model with two subcompartments. After a brief description of the cardiac 
compartment of the model, the mass balance equations written for O2 and CO for 
each blood and cardiac tissue subcompartment are explained in detail. Parameter 
estimation for the cardiac compartment and development of predictive equations are 
also discussed in this chapter. Predictive equations are developed for: (i) estimating 
the volumes of muscular regions (arms, legs and trunk) for males and females (ii) 
percent increase in cardiac output and heart rate as functions of increased HbCO 
levels in the blood, (iii) cardiac output and heart rate as functions of total body 
oxygen consumption, (iv) percent increase in heart rate as a function of increased 
HbCO levels in the blood. Estimation equations were also developed for: (v) 
myocardial oxygen consumption, and (vi) myocardial blood flow, both as functions 
of heart rate. Sensitivity analysis is performed and parameters that influence the 
oxygen tension in the myocardial tissue and vascular PO2 are determined. This 
chapter also explains the validation protocol for the cardiac compartment of the whole 
body model where predicted data are compared with experimental values (from 
humans and animals during conditions of normoxia, hypoxia, exercise and 
hyperoxia).  
 
3.1 Overview of Desired Model 
In our lab, the initial model (referred to as the primary model in this thesis, 
Figure 2.1) developed by Dr. Bruce (2003) was modified to produce a second model 
(referred to as the modified model in this thesis, Figure 3.1), which accounts for mass 
balance of oxygen (Bruce, Bruce, and Erupaka, manuscript in preparation).  
Additions in this model include O2 mass balance equations, an algorithm to calculate 
PO2 corresponding to the concentration of oxygen halfway between the inlet and 
outlet of the vascular subcompartment of a tissue, and a regression equation to predict 
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the associated increase in cardiac output due to an increase in COHb level in the 
blood. Also, skeletal muscle mass was distributed into volumes of muscular regions 
(arms, legs and trunk) for males and females to account for regional heterogeneities in 
muscle blood flow (Table 2.3) and O2 consumption (Table 2.4). The physiological 
phenomenon of arterio-venous shunting was implemented in the lungs. Later, in an 
enhancement of the modified model, a two subcompartment cardiac compartment 
was added (referred to as the final model in this thesis, Figure 3.2). Development of 
this cardiac compartment in the model is the first main goal of this thesis. 
 
The skeletal and cardiac muscles exhibit major differences in morphology, 
blood flow and O2 demand. Also, cardiac muscle works constantly to pump blood 
unlike the skeletal muscle, and it would be inappropriate to lump the cardiac muscle 
with the resting skeletal muscle. In the process of building the cardiac compartment 
various other prediction equations were developed to estimate parameters needed for 
the model. Parameters like myocardial O2 consumption and myocardial blood flow 
were predicted as functions of heart rate; cardiac output and heart rate were calculated 
from body oxygen consumption when values for heart rate and cardiac output were 
not available. Also, increase in heart rate was predicted as a function of increased 
COHb levels in blood.  
 
3.2 Modified Model 
The modified model consists of five major compartments: 1.The arterial blood, 
2. The Lungs, 3. Skeletal Muscle with two subcompartments, 4. Non-muscle tissue 
and 5. Mixed venous blood compartments (Figure 3.1). Mass balance equations are 
written for oxygen (O2) and carbon monoxide (CO) for each of these compartments to 
model whole body uptake of, and distribution of, CO and O2.  Section 3.2.1, explains 
the mass balance equation of O2 for the alveolar compartment, and Sections 3.2.2 and 
3.2.3 introduce the general form of mass balance equations of O2 and CO for the 
vascular and tissue compartments of the modified model.  
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3.2.1 Mass Balance Equations for the Alveolar Compartment 
The O2 mass balance equation for the alveolar compartment was added to the 
model as follows,  
  LB
B
A
Ai
A
L fluxOP
VtOPtOP
dt
tOdCV 2
.
22
2 )]()([)( −−=  
where, VL is lung volume, CAO2 is the alveolar O2 concentration, PAO2 is the 
alveolar partial pressure of oxygen , PiO2  is inhaled PO2, t is time, .AV  is alveolar 
ventilation,  PB is barometric pressure,  and )(2 tfluxO LB  is the oxygen flux from lungs 
to blood, defined as 
 
  )]()()[1()( 22
.
2 tOCtOCSFQtfluxO mxepLB −−= . 
 
Where Q. is the cardiac output and SF is the shunt fraction, the percentage of 
pulmonary blood flow that passes from the right to left heart without undergoing 
oxygenation by the lung. CepO2 (t) is the end pulmonary oxygen concentration and 
CmxO2 (t) is the oxygen concentration in the mixed venous compartment. It is 
assumed that the end pulmonary partial pressure of oxygen (PepO2) equals alveolar 
partial pressure of oxygen (PAO2). CO mass balance equations for the alveolar 
compartment are used from the primary model which was discussed in Section 2.1 of 
chapter 2. 
 
3.2.2 Mass Balance Equations for Blood Compartments 
The mass balance equations for O2 in the arterial, mixed venous and vascular 
subcompartments of the skeletal muscle tissue are each described by an equation of 
the general form 
   )()].()([
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2 tFluxOQtOCtC
dt
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V iii
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where i is the index representing the arterial (ar), mixed venous (mx), skeletal 
muscle (subcompartment m1 or m2), or venous (v) compartments. iV is volume of 
the compartment i, iniC  is the concentration of O2 in blood entering the compartment 
 35 
i, 2OCi  is the total concentration of O2 in the blood compartment i, and Fluxi is the 
rate of diffusion of O2 out of the vascular compartment i. (Mass balance equations of 
O2 and CO for individual cardiac compartments are discussed in Section 3.3 of this 
chapter.) 
The flux is zero for the arterial and venous blood compartments. For the non-
muscle (other) - tissues (ot) blood compartment, the )(tFluxot  is defined as 
  2222 )].()([)( ODtOPtOPbtFluxO otototot −=  
where, )(2 tOPbot  is the mean partial pressure of O2 in the arterial inflow and 
venous outflow of the non-muscle vascular compartment. )(2 tOPot  is the partial 
pressure of O2 in the non-muscle tissue compartment. 2ODot , is the blood to tissue 
diffusion coefficient of oxygen. The non-muscle soft tissue in the model is a single 
compartment.  Because it does not contain Mb, its uptake of CO is very small. 
For the skeletal muscle (m) blood subcompartments, the general form of the 
equation for )(tFluxmj is as follows: 
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where j is the index of the blood vascular subcompartments j =1,2,3 for blood 
subcompartments 1 ,2 and 3, respectively. 2OD mjb  is the blood to muscle tissue 
diffusion coefficient. )(2 tOP mjb is the partial pressure of O2 corresponding to the 
concentration of oxygen halfway between the inlet and outlet of the vascular 
subcompartment of the skeletal muscle. )(21 tOPm  and )(22 tOPm  are the two 
subcompartment (m1, m2) tissue O2 tensions. 1mV  and 2mV  are the volumes of the 
muscle tissue  subcompartment 1 and 2, respectively. SO2 is the solubility of oxygen 
in plasma and PSm is the permeability surface area product of the skeletal muscle. 
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Gsf(P) is a heuristic “gain” whose only purpose is to reduce the diffusion coefficient 
in hyperbaric O2 (which is not considered in this thesis). During hyperbaric O2, 
hemoglobin is completely saturated with O2 and dissolved O2 concentrations increase, 
thereby resulting in a decrease of the effective diffusion coefficient of O2. Gsf = 1 for 
all simulations herein. The diffusion coefficient of O2 is directly proportional to 
permeability surface area product. Greater permeability of the membrane for O2 
means that the diffusion coefficient of O2 from blood is greater and efficiency of O2 
transport from blood to tissue is greater. O2 flux depends on the pressure gradient and 
the diffusion coefficient, Dbm(j=1,2,3)O2. 
The total concentration of O2 in the blood compartment, )(2)3,2,1( tOC j= , is 
calculated from dissolved and Hb-bound O2 concentration components so that 
 
  )(.)()( 2222)3,2,1( tOPSOtHbOtOC jjj +== , 
 
where O2Hb is the oxygen bound to hemoglobin, )(2)3,2,1( tOP j= is the partial pressure 
of O2 in the muscle blood subcompartment j. 
 
Mass balance equations for CO in the arterial, mixed venous and non-muscle 
tissue are described in reference 35. CO mass balance equations for vascular 
subcompartments of the skeletal muscle are each described by an equation of the 
form 
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where i=m1 or m2, the index representing skeletal muscle subcompartment 1 
(m1), or muscle subcompartment 2 (m2). )(tCOCini  is the concentration of CO in 
blood entering the compartment i, COCi  is the total concentration of CO in the 
blood compartment i, 
 
  )(.)()( tCOPSCOtCOHbtCOC iii +=  
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COFluxi is the rate of diffusion of CO out of the vascular compartment.  
  ( )[ ])()()( 2)(1)3,2,1( tCOPtCOPCODtCOFlux mormmjbmjbjm −⋅==  
COD mjb  is the blood to muscle tissue diffusion coefficient and is estimated by 
fitting the model to experimental data (35).  )(tCOP mjb is the average partial pressure 
of CO of the vascular subcompartment j of the tissue. )(1 tCOPm  and )(2 tCOPm are the 
partial pressures of CO in the muscle tissue  subcompartments 1 and 2, respectively. 
CO mass balance equations for non-muscle tissue are the same as those in the primary 
model. 
 
3.2.3 Mass Balance Equations for the Tissue Compartments 
The mass balance equations for O2 for the first skeletal muscle subcompartment 
(m1) in the two subcompartment skeletal muscle model is 
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Second subcompartment m2: 
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where,  DmO2 is the diffusion coefficient of O2 between the two 
subcompartments (m1, m2) of the skeletal muscle tissue. )(21 tOCm  and )(22 tOCm are 
the partial pressures of O2 of the two muscle subcompartments 1 and 2. Dxm is the 
intercapillary distance. The )(21 tOFluxm and )(22 tOFluxm  are defined as 
  12321221 )()()( mmmm MROtFluxOtFluxOtOFlux −+=  
  222222 )()( mmm MROtFluxOtOFlux −=  
where, 
)(12 tFluxO m , )(22 tFluxO m  and )(32 tFluxO m  are the O2 diffusion rates of 
vascular blood compartments 1, 2 and 3, respectively. MRO2m1 and MRO2m2 are the 
O2 metabolic rates of  the tissue subcompartments 1 and 2, respectively. O2 diffuses 
from the vascular to the extra vascular compartments based on the pressure gradient 
between the compartments and the blood-to-tissue diffusion coefficients.  
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The CO mass balance equation for the two compartment tissue model is 
First subcompartment m1: 
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Second subcompartment m2: 
                      
[ ]
xm
mmm
m
mm
D
tCtCD
V
tFlux
dt
tdC )(CO)(COCO)(CO)(CO 21
2
22 −+=  
where, the subscripts and parameters are the same as those above, except,  DmCO 
is the diffusion coefficient of CO within the two subcompartments of the tissue. 
)(CO1 tCm  and )(CO2 tCm  are the CO concentrations of the two tissue 
subcompartments 1 and 2, respectively. )(1 tCOFluxm  and )(2 tCOFluxm  are defined 
as 
)()()( 311 tCOFluxtCOFluxtCOFlux mmm +=  
)()( 22 tCOFluxtCOFlux mm =  
where )(1 tCOFluxm , )(2 tCOFluxm  and )(3 tCOFluxm  are defined in the blood 
compartments. The only difference between the mass balance equations for CO and 
O2 is that oxygen is metabolized to meet the tissue metabolic demand while CO is not 
metabolized. 
 
3.2.4 Prediction equations in modified model: 
 Predictive equations were developed as part of this thesis and added into the 
model to account for the blood flow and metabolic O2 demand heterogeneities in the 
skeletal muscle tissue. Also there is an observed increase in cardiac output during CO 
exposure (68,69,70). Regulation of cardiac output in response to blood HbCO levels 
has been implemented into the model. 
Prediction equations to estimate the volumes of regions (arms, legs and trunk 
for males and females) of skeletal muscle model: Muscle metabolic rate (MRO2m) is 
reported to be 20% (88, 89) of the total body oxygen consumption (MRO2) during 
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rest. The metabolic rates of O2 for leg, arm and trunk muscles are different (Table 
2.4).  Also the blood flows to different regions of the skeletal muscle vary (Table 
2.3).  Thus, to incorporate these heterogeneities (different metabolic rates and blood 
flows) of muscle in various regions, the skeletal mass is distributed into three muscle 
volume compartments namely leg muscle volume, arm muscle volume, and trunk 
muscle volume. The derivation of the equation is detailed in the appendix. The 
equations (Table 3.1) for calculating the masses of trunk, leg and arm muscle are 
functions of total skeletal muscle mass, Vm (41).  
 
Tabulated blood flows and O2 consumptions for skeletal muscle tissues are 
shown in table (Table 2.3 and Table 2.4) of the chapter 2. So after estimating the 
volumes of the skeletal muscle regions, average values (Table 3.2) for blood flow and 
oxygen consumption were determined for the muscular regions (arms, legs and 
trunk). From the Table 2.2 and Table 2.3, blood flow and oxygen consumption 
heterogeneity within the submuscular regions of arm (biceps, triceps, brachioradialis 
etc) and leg (gastrocnemius, biceps femoris etc) muscular regions can be clearly seen. 
Thus to determine the blood flow (or oxygen consumption) for the muscular regions 
(arms, legs and trunk), an average of the blood flows (or oxygen consumption) from 
different submuscular regions of the arm was taken. For example, to estimate the 
blood flow for the arm muscular region an average of all reported blood flows ( in 
ml/min/gm) for the biceps, the triceps and the brachioradialis muscles was 
considered.  Data for blood flow and oxygen consumption for the trunk muscles in 
healthy humans has not yet been reported in the literature. Hence, blood flow and O2 
consumption for the trunk muscular region was assumed to be equal to that of the leg 
muscular region. Blood flow for muscles in the trunk region was reported in animals 
(71, 72), but these values could not be considered due to postural differences in 
humans (bipedalism) and animals (quadrupedalism). There are some constantly 
working muscles in the trunk region like diaphragm (aid in breathing) which implies 
that blood flow and myocardial O2 consumption must be higher than the arm 
muscular region. Also the muscles in the leg region work constantly against gravity to 
maintain postural balance. Since the leg and trunk muscle regions are mildly working 
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skeletal muscle regions, an assumption of equal blood flow and O2 consumption was 
made. 
 
 There is reported to be an increase in cardiac output and heart rate with 
increase in carboxyhemoglobin levels in blood (68, 69, 70). When simulating 
experiments, increased carboxyhemoglobin levels in the blood had to be taken into 
account. Data for cardiac output, heart rate and carboxyhemoglobin (up to 50%) were 
collected from reference 68 and 69. Linear or nonlinear regression was performed on 
data, and statistical significance of the equations was tested using SYSTAT 9.0 after 
outliers were eliminated. The resulting equation was tested with data (70) which were 
not used in the regression. Then the equation was implemented into the model. A 
detailed derivation of the equation below is discussed in appendix. Figure 3.3 shows 
the data points used to build the regression relation and the relation fit developed for 
predicting the increase in cardiac output as a function of blood HbCO levels, as 
shown below 
    )(%572.0% HbCOQ Δ=Δ &   
3.3 The Cardiac Compartment 
 The myocardial compartment comprises three vascular subcompartments; 1, 2, 
3 as shown in the Figure 3.4 and two tissue subcompartments; 1 and 2.  The arterial 
blood which has a partial pressure of O2, ParO2, flows into the first vascular 
compartment 1, which has a blood volume of Vbcm1. O2 in blood is present in two 
forms: (1) dissolved in plasma and (2) reversibly combined with hemoglobin 
molecules forming oxyhemoglobin (O2Hb). Oxygen continuously diffuses into the  
tissue compartment 1 as oxygen is being utilized by the tissue to meet metabolic 
demand (MRO2cm1 ), causing tissue PO2 to be lower than that of the PO2 in the blood. 
It is assumed that O2 diffuses from the vascular subcompartment 1 to the 
extravascular subcompartment 1 of the tissues at a rate O2fluxcm1 which is based on 
the oxygen diffusion coefficient Dbcm1O2 and O2 pressure gradients between the 
blood and tissue. This phenomenon establishes O2 concentrations of Ccm1O2 and 
Ccmv1O2 in the first tissue and blood subcompartments, respectively. In all tissue 
compartments O2 bound to myoglobin is considered in addition to the prevailing O2 
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concentrations. The tissue compartment 1 which has a volume Vcm1 is assumed to be 
perfused by small arterioles and small venules, as well as by capillaries (Figure 3.5).  
The permeability surface area product for O2 in this tissue compartment is PScm1O2.  
The oxygen tension prevailing in the blood exiting from compartment 1, Pcmv1O2, is 
the source for the O2 supply to the second blood compartment 2 which has a blood 
volume Vbcm2. There is diffusion of O2 from the blood compartment 2 to the tissue 
subcompartment 2 at rate of O2fluxcm2 with the diffusion coefficient being Dbcm2O2. 
The metabolic demand of O2 (MRO2cm2), of this tissue compartment is met by 
diffusion of oxygen from the vascular compartment 2 and also by diffusion from the 
tissue compartment 1 with a diffusion coefficient of DcmO2. Approximately 15% of 
the metabolic rate of the tissue compartment 2 is met by diffusion of O2 from its 
neighboring tissue compartment 1. The tissue compartment 2, which has a volume 
Vcm2, is perfused mostly by capillaries (Figure 3.5) and has a permeability surface area 
product of PScm2O2.  Diffusion of O2 establishes O2 concentrations of Ccm2O2 and 
Ccmv2O2 in the second tissue and blood subcompartments, respectively.  Now the 
oxygen tension of blood exiting from the vascular subcompartment 2, Pcmv2O2 is the 
O2 source for the vascular compartment 3 which has a blood volume of Vbcm3. Based 
on the pressure gradients established between tissue compartment 1 and the third 
blood compartment 3, there is flow of O2 at a rate of O2fluxcm3 from the tissue 
compartment 1 into the blood compartment 3, resulting in an O2 concentration of 
Ccmv3O2 in the third blood subcompartment. The O2 diffuses with a coefficient of 
Dbvcm1O2. However, when the tissue PO2 is lower than the PO2 in the third blood 
compartment then O2fluxcm3 is positive, indicating that O2 diffuses from the third 
blood compartment to the tissue compartment 1. Because O2 diffusivity is similar in 
plasma and muscle tissue (77), the model assumes that O2 diffusion coefficients from 
blood to tissue or vice versa are equal. The concept of the two compartment model 
was introduced to allow diffusion of oxygen within the tissue and also to implement 
indirect arterio-venous shunting.  Description of cardiac variables are summarized in 
Table 3.3. 
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3.3.1 Mass Balance Equation of the Cardiac Vascular Blood Compartments: 
The equations below are the mass balance equations for the three vascular blood 
compartments,  
Cardiac vascular blood compartment 1: 
Mass balance equations for O2 
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Mass balance equations for CO 
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where, Paacm is the partial pressure of O2 corresponding to the concentration of 
oxygen halfway between the arterial (inlet) and vascular subcompartment 1 (outlet). 
Paacm is determined by an algorithm using a gradient search technique, where the 
average O2 concentration is calculated and then the PO2 corresponding to the average 
O2 concentration is determined using the oxyhemoglobin saturation curve. Pbcm1, is 
the average partial pressure of CO in the blood vascular subcompartment 1. Dbcm1CO 
is the blood to tissue CO diffusion coefficient, DMCO1 is the blood to muscle 
diffusion coefficient of CO in blood compartment 1 and Dbcm1O2 is the blood to 
tissue oxygen diffusion coefficients of cardiac blood compartment 1. DbM1O2, 
DbM2O2 and DMCO are blood to tissue O2 and CO diffusion coefficients of muscle 
blood compartments described in Section 3.2. All other variables are defined 
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 in Table 3.3. 
      
     Cardiac vascular blood compartment 2: 
  
Mass balance equations for O2 
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Mass balance equations for CO 
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Where Pbbcm is the partial pressure of O2 corresponding to the concentration of 
oxygen halfway between the inlet (Pcmv1O2) and outlet (Pcmv2O2) of vascular 
subcompartment 2. Dbcm2O2 is the blood to tissue diffusion coefficient. Pbcm2 is the 
average partial pressures of CO in the blood vascular subcompartment 2. Dbcm2CO is 
the blood to tissue diffusion coefficient, DMCO is the blood to muscle diffusion 
coefficient of CO in blood compartment 2 and Dbcm2O2 and Dbm2O2 are blood to 
tissue oxygen diffusion coefficients of cardiac and muscle blood compartment 2. All 
other variables are define in Table 3.3 
 
       Cardiac vascular blood compartment 3: 
Mass balance equations for O2 
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where Pcccm is the partial pressure of O2 corresponding to the concentration of oxygen 
halfway between the inlet (Pcmv2O2) and outlet (Pcmv3O2) of vascular subcompartment 
3. Dbvcm1O2 is the tissue to blood diffusion coefficient, Dbvcm_on is the fraction of  
blood volume in cardiac vascular compartment 1 (Vbcm1) available for gas exchange 
with (venules) cardiac vascular compartment 3 (Vbcm3). Pbcm3 is the average partial 
pressure of CO in the blood vascular subcompartment 3. Dbvcm1CO is the blood to 
tissue diffusion coefficient. Dbvcm1O2 is the blood to tissue oxygen diffusion 
coefficient of cardiac blood compartment 3. DbvM1O2, DbM2O2 and DMCO3 are 
blood to tissue O2 and CO diffusion coefficients of muscle blood compartments 
described in Section 3.2. All other variables are defined in Table 3.3 
 
The O2 concentration at the input to the mixed venous compartment is 
determined by a flow-weighted summation of the concentrations of O2 in the venous 
outflow from the tissue compartments. This input concentration then passes through 
the mixed venous compartment and returns to the lungs after a time delay. Thus the 
O2 concentration at the input to the mixed venous compartment is 
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Where, 
)(2 tOCvot , )(2 tOCm , )(2 tOCcm  are the O2 concentrations in the non-muscle, 
skeletal muscle, and cardiac muscle tissues, respectively. ... ,, cmmot QQQ  are the blood 
flows to the non-muscle, skeletal muscle, and cardiac muscle tissue compartments, 
respectively.  
 
3.3.2 Mass balance equation of the cardiac tissue subcompartments : 
First cardiac tissue subcompartment: 
The mass balance equation for O2 in the first tissue subcompartment is 
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where )(21 tOFluxcm is defined as 
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)(),( 2221 tOCtOC cmcm  are the total O2 concentrations in the first and second 
tissue compartments, )(21 tOPbcm  and )(22 tOPbcm are the partial pressures of O2 of the 
two tissue subcompartments. O2Fluxcm1 and O2Fluxcm3 are the blood O2 fluxes of 
subcompartments 1 and 3 defined in Section 3.3. MRO2cm1 is the metabolic rate of O2 
in the tissue compartment 1. 
The mass balance equation for CO in the first tissue subcompartment is 
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)(),( 21 tCOCtCOC cmcm  are the CO concentrations in the first and second tissue 
compartments. CO Fluxcm1 and CO Fluxcm3 are the rates of CO  fluxes of the blood  
subcompartments 1 and 3.  
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Second cardiac tissue subcompartment: 
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where )(22 tOFluxcm is defined as  
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)(),( 2221 tOCtOC cmcm  are the O2 concentrations in the first and second tissue 
compartments, )(21 tOPbcm  and )(22 tOPbcm are the partial pressures of O2 of the two 
tissue subcompartments. O2Fluxcm2 is the blood O2 flux of subcompartment 2 defined 
in Section 3.3.  MRO2cm2 is the metabolic rate of O2 in the tissue compartment 2. 
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where )(2 tCOFluxcm is defined as 
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)(1 tCOCcm  and )(2 tCOCcm  are the CO concentrations in the first and second 
tissue compartments. CO Fluxcm2 is the CO  flux of the blood subcompartment 2.  
 
3.4 Parameters for the Model 
Estimating parameters for a model is a crucial task. The heart muscle is similar 
to exercising skeletal muscle. Constant exercise results in the heart muscle parameters 
being different from the skeletal muscle. There are marked regional variations in flow 
and oxygen consumption (Table 2.1, Table 2.2). Blood flow, oxygen consumption 
and capillary density of per unit mass are greater in cardiac muscle than in resting 
skeletal muscle. Capillary density/gm is ~8 times greater in cardiac muscle than in 
skeletal muscle (39). Higher capillary density promotes efficient O2 transport from 
blood to tissues and also within the tissue. Because blood flow and O2 consumption 
increase with workload and as the heart is a vigorously working blood pump, it has a 
higher blood flow and a vasculature designed for efficient O2 delivery to match the O2 
demand. There is parameter heterogeneity (blood flow, oxygen consumption, regional 
tissue oxygen tension, capillary density) within the various regions of the heart, the 
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epicardium, myocardium and endocardium (Table 2.5, 73, 74, 75).  Also, the 
chambers of the heart (right atrium, left atrium, left ventricle and right ventricle) and 
the septa separating them have varied blood flow and oxygen consumption (Table 
2.1,Table 2.2).The weight of the heart varies with age, gender and ethnicity of the 
subject (76). Keeping in mind the inhomogeneity of heart muscle, parameters were 
estimated from the available literature. 
Nominal values for most of the parameters were obtained from the literature or 
directly from the investigators whose data we simulated e. g., total body metabolic 
rate, heart rate, cardiac output etc. In some cases parameters were estimated with 
average values from a group of subjects or published predictive formulas in literature 
e.g., volume of heart, blood volume, myocardial myoglobin concentration etc. 
Parameter values were also estimated from predictive formulas described previously 
in this thesis, e. g., myocardial O2 consumption, myocardial blood flow etc. There are 
parameters like the permeability surface area product of the compartments, which 
have a value at resting conditions but linearly increase in proportion to the blood flow 
(90). There are some parameters like cardiac muscle volume fraction (Fvcm) and 
fraction (Dbvcm_on) of  blood volume in the cardiac vascular compartment 1 
(Vbcm1) available for gas exchange with (venules) cardiac vascular compartment 3 
(Vbcm3) that represent quantities that are very difficult, or even impossible to 
measure. Values of such parameters are unknown and estimates are made for these 
values based on physiology.  Parameters in this model are classified based on their 
estimation method:  
1. Physiological parameters 
2. Model-derived parameters 
3. Simulation parameters 
 
3.4.1 Physiological parameters 
 These parameters are constants whose values can be found from the literature 
or from experimental measurements available. Some physiological parameters are 
body weight (BW), solubility of O2 in plasma (SO2), blood flows to a specific 
compartment, etc. Most of these parameters are estimated by taking an average of 
 48 
several published values like myoglobin concentration (Table 3.4), values present in 
literature like the volume of heart, fraction of blood etc or are directly obtained from 
the experimental database to be simulated. The physiological parameters are listed in 
Table 3.5 
 
3.4.2 Model-derived parameters  
These are the parameters whose values are estimated in the model from 
predictive equations, e.g.,  myocardial blood flow, myocardial O2 consumption etc or 
from formulas like the diffusion coefficients for O2 and CO or volumes of tissue 
compartments. The model-derived parameters are listed in Table 3.6  
 
3.4.3 Simulation parameters 
These parameters are intermediate values of the model which help to establish 
the simulation conditions. These parameters are used in accessory equations that are 
needed for evaluating the derivative functions for numerical integration; aid in 
simulating experimental conditions (e, g., TW, TZSS etc.). Simulation parameters 
specific to ACSL are the time step (CINT) of the algorithm, the integration algorithm 
used (IALG), TMAX etc. Simulation parameters are listed in the Table 3.7  
 
3.5 Predictive Equations in the Model 
Prediction equations for estimating model parameters were implemented into 
the model either from  the literature (published journals) or were developed especially 
for the thesis. The following prediction equation for estimating blood volume in 
humans was reported in reference 78. Thus the prediction equation for estimating 
blood volume (when its value is not available) was added into the model:  
  Volume of blood =
2)(22/_
70
HTpBMI
 (78) 
    BMI= 2)(HT
bw  
    delta_IBW= 100
22
⎟⎠
⎞⎜⎝
⎛ BMI  
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    BMI_p= 2222
100
_ +⎟⎠
⎞⎜⎝
⎛ IBWdelta , 
where BMI is the body mass index, bw is the body weight  and HT is the height 
of the subject. 
 
Estimation equations were developed for myocardial oxygen consumption and 
myocardial blood flow as functions of heart rate, and for cardiac output and heart rate as 
functions of total body metabolic rate. Data to establish values for parameters of these 
equations were collected from various papers in the literature. Linear or nonlinear 
regression was performed on data (different model/order of equations were checked)  and 
statistical significance of the equations was tested using SYSTAT 9.0 after outliers were 
eliminated. The resulting equation was validated with data which was not used in the 
regression. Then the equation was implemented into the model. The following prediction 
equations were developed as part of this thesis to estimate values for unknown 
parameters of the model. 
 
3.5.1 Prediction Equations for Myocardial Oxygen Consumption  and Blood 
Flow 
Myocardial oxygen supply and oxygen demand balance are very important for 
the tissue to be viable. Data from various published papers (80-86) of myocardial 
oxygen consumption and myocardial blood flow were tabulated. The strategy 
followed for developing the prediction equation is shown in Figure 3.6. The data used 
to develop the prediction equation had values obtained during rest and exercise 
conditions. Most of the blood flow data for humans was from studies that used the 
nitrous oxide dilution method. But the nitrous oxide method is reported to have 
certain limitations (87) which tend to under-estimate the true blood flow; values 
based on this method resulted in oxygen supply and demand mismatch when 
implemented into the model. Thus, to predict the myocardial blood flows, data from a 
published experiment (79) was used to derive the predictive formulas. The steps 
described below were followed to establish the relations. 
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1. Constructed regression relation for myocardial blood flow as a function of heart 
rate. Data for regression relation was obtained from the reference 79. Myocardial 
blood flow in their study was measured by dynamic PET (Positron Emission 
Tomograph) accompanied by intravenous injection of labeled water ([15O]H2O). 
Data used for deriving the relation and its fitted equation using linear regression is 
shown in Figure 3.7 
2. The next step was to correct the myocardial oxygen consumption data which was 
calculated using FICK’s method, where oxygen consumption is measured as a 
product of myocardial blood flow and Arterio –Venous oxygen differences. 
Myocardial oxygen consumption data had to be corrected as the papers from 
which (80-86) myocardial oxygen consumption data was available used blood 
flow measurements based on the nitrous oxide method to calculate oxygen 
consumption. The approach taken for correcting the myocardial oxygen 
consumption is as follows: 
(i) A-V difference was calculated as ratio of myocardial oxygen consumption 
and myocardial blood flow values obtained from studies using the nitrous 
oxide method. 
(ii) Corrected myocardial oxygen consumption = Product of blood flow                
calculated for heart rates in the nitrous oxide papers using regression relation 
developed in step 1 and A-V differences (calculated in step 2(i)). 
3. After the myocardial oxygen consumption values were corrected for the 
differences in the methods, a non-linear curve fit was done using MATLAB to 
establish myocardial oxygen consumption as a function of heart rate. Data used to 
derive the relation and its fitted equation using nonlinear regression is shown in 
Figure 3.8 .The relation obtained is as follows: 
 
Myocardial Oxygen Consumption =  
 
where, 
HR= heart rate, 
a= 56.3217, asymptotic maximum, 
      a-d             d 
 1 + (c/HR)b 
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b= 4.8485, defines the slope of the function,  
      c= 122.6617, c is the value of the independent variable x at the inflection point. 
 d= 9.7643, asymptotic minimum. 
 
Thus, to determine the myocardial oxygen consumption (ml/min/100gm) and 
myocardial blood flow (ml/min/100gm), the following predictive formulas were 
developed: 
   Myocardial Blood Flow (Q۠cm) = 2.18 * (HR) – 27.3 
                                                             
    Myocardial Oxygen Consumption (MRO2cm) =                                                           
 
 
3.5.2 Prediction Equations for Cardiac Output 
Cardiac output (Q.) was previously estimated as a function of body weight and 
gender. This equation could be used only during conditions of basal rest. Since we 
wanted to simulate experimental conditions of exercise where the cardiac output 
increases, we developed equations to predict cardiac output as a function of total body 
oxygen consumption (MRO2). Cardiac output and total body oxygen consumption 
values were collected from various papers in the literature (See the appendix.). The 
data were obtained at rest and various loads of exercise. The tabulated aggregated 
data were fit with a 2nd-order polynomial as shown in the appendix.  Thus the 
equation developed is  
  Q˙ =3.186+7.346xMRO2 - 0.535x (MRO2)2 
 
3.5.3 Prediction Equations for Heart Rate 
Often for the experiments we simulated, the investigators provided heart rates of 
the subjects at rest. In simulation cases where heart rate data were not provided we 
estimated the heart rate as function of total body oxygen consumption from the 
equation below. The procedure for developing the equation is detailed in the 
appendix. The heart rate parameter is used for estimating the myocardial oxygen 
     56.3217-9.7643      9.7643 
 1 + (122.6617/HR) 4.8485 
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consumption and myocardial blood flow which is discussed in Section 3.5.1 of this 
chapter.  
 
  Heart Rate (HR) = 42.819+68.884*(MRO2)-8.26* (MRO2)2 
 
Predicting percent increase in the heart rate (HR) as a function of percent 
change of carboxyhemoglobin (% ∆COHb) levels in blood: There is reported to be an 
increase in cardiac output and heart rate with increases in carboxyhemoglobin levels 
in blood (68,69,70). While simulating experiments involving carbon monoxide (CO) 
exposures, increased heart rate due to increased carboxyhemoglobin levels in the 
blood had to be taken into account. These increases were implemented by introducing 
the following equation whose derivation is discussed in the appendix. 
   )(%26.0)(%012.0% 2 COHbCOHbHR Δ+Δ=Δ  
The heart rate (HR) was increased by %∆HR respectively, calculated from the 
above equations every 0.001 min of simulated time.  
 
3.6 Sensitivity Analysis: 
Sensitivity analysis is used to determine how “sensitive” a model is to changes in the 
value of the parameters of the model and to changes in the structure of the model. It 
surveys how a given model output depends upon its parameter values. It is an 
important method for checking the quality, robustness and reliability of analyses and 
for building confidence in the model by studying the uncertainties that are often 
associated with parameters in models. It helps to determine the level of accuracy 
needed for a parameter to make the model sufficiently useful and valid. The process 
involves varying model parameters (one at a time, keeping other parameters constant) 
over a reasonable range (especially when there is an uncertainty in values of the 
varied parameter) and observing the relative changes in model response.  If the testing 
process reveals that the parameter varied has no significant effects on the model 
response, then it may be possible to use an estimate rather than a value with greater 
accuracy. But if the system behavior greatly changes with the varied parameter then 
an accurate value should be determined for that parameter. If the value of the 
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sensitive parameter is unknown in from the literature, then doing sensitivity analysis 
helps to estimate deviations in model predictions with the parameter variation.  Thus 
sensitivity analysis was done to analyze the effect of model parameters on the model 
predictions of myocardial tissue PO2 and coronary venous PO2. It was found that the 
predicted myocardial tissue PO2 and coronary venous PO2 are most sensitive to 
variations in the myocardial blood flow (Q•cm), myocardial oxygen consumption 
(MRO2cm), permeability surface area product (PScm), and volume distribution 
fraction of the tissue (FVcm). Table 3.9 shows the values of predicted myocardial 
tissue PO2 and coronary venous PO2 with variations in the input parameters. In this 
table myocardial O2 consumption (MRO2cm ), myocardial blood flow (Q·cm), PS 
product (Pscm),  AV Shunt fraction (Dbvcm_on), volume distribution (Fvcm) and, 
inter capillary distance (Dxcm) were increased (and decreased) by 50% and the 
response of the model predictions - i.e. tissue and blood oxygen tensions - to variation 
of these parameters was tabulated (Table 3.8).   
 
After doing the sensitivity analysis, a standard set of values for the following 
parameters (PScm, Fvcm,Dbvcm_on, Dxcm), whose values were difficult to estimate 
(due to unavailability of data)  was determined. The values for these parameters are 
shown in table 3.7. This standard set of parameters was arrived at after analyzing the 
coronary physiology, vasculature density in myocardium and other experimental facts 
such as the extent of hypoxia, exercise or CO exposure which did not cause 
permanent injury or death of the subject. The volume of the cardiac compartment 
(Vcm) is divided into two subcompartments of volume Vcm1 and Vcm2 by means of 
the cardiac muscle volume fraction (Fvcm). The value for Fvcm was estimated to be 
0.2 in order to make best estimates for tissue PO2.   The permeability surface area 
product of O2 for cardiac muscle model was reported to be 200 ml/min/Torr/gm by 
Beard and Bassinghwaite (90). When the above reported value for permeability 
surface area product was used, final model predicted myocardial tissue PO2’s were 
very low. The best estimates for tissue PO2 predictions were obtained when the PS 
for the first and second cardiac subcompartments were 180 ml/min/Torr/gm and 450 
ml/min/Torr/gm, respectively. There is reported to be capillary recruitment during 
 54 
exercise in skeletal muscle (102). However, the extent of capillary recruitment in 
myocardium during exercise is unknown. Increase in capillary recruitment would 
increase the PS as the surface area available for oxygenation would increase. PS is 
reported to increase with blood flow (90), thus in the final model PS increases with 
increases in blood flow.  The intercapillary distance in skeletal muscle in the modified 
model is 0.1 cm. The capillary density in cardiac muscle is approximately 8 times 
greater than that of the skeletal muscle (39), thus the intercapillary distance for 
cardiac compartment in the final model is 0.0353 cm (0.1/√8). Fraction (Dbvcm_on) 
of blood volume in cardiac vascular compartment 1 (Vbcm1) available for gas 
exchange with (venules) cardiac vascular compartment 3 (Vbcm3) was estimated by 
analyzing the coronary vasculature (103,104). Also from the sensitivity analysis, it 
can be seen that Dbvcm_on does not have a significant impact on the model 
predictions of myocardial tissue PO2 and coronary venous PO2. A value of 9.5% was 
chosen for Dbvcm_on as better estimates for coronary venous PO2 and myocardial 
tissue PO2 were obtained for that value. 
 
3.7 Validation Schema for the Cardiac Compartment 
The final model (Figure 3.4) was used for the simulations to test the validity of the 
predicted O2 related variables of the cardiac compartment. Predictions from the 
model were compared with published observations on human subjects and animal 
data. The model was tested for conditions of normoxic rest (91,92,95,99,100), 
hypoxic rest (91,92,93,98), hypoxic exercise (91) and hyperoxia (93,94,96,97,98) 
with regard to its predictions of coronary venous PO2 and tissue PO2. For validation 
of human data, subject morphological data like body weight, age, etc., were used  
The protocol for validation of the model was as follows: 
1.      Inspired levels of O2 were set equal to the experimental values. Ventilation 
was adjusted to achieve the measured arterial PO2 in the steady state. 
2.   Experimentally measured values for myocardial O2 consumption and 
myocardial blood flow were used in the simulations. 
3. Each simulation was allowed a stabilization time of 12 min (simulation time) 
and the model predictions were noted after reaching steady state. 
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4. The model predictions of cardiac oxygen tensions and coronary venous PO2’s 
for various conditions were compared to experimental data 
5. Usually, experimental tissue PO2 values were available as either mean values or 
as histograms. When a mean value was published, based on the size of the 
electrode used to measure PO2, it was either classified as the average first 
compartment (large electrode, assuming it was close to an arteriole) or second 
compartment PO2.  In the case of histograms, the mean value was used to 
represent the average tissue PO2. An average of the PO2 in the histogram 
above the mean was considered as the first compartment oxygen tension and 
an average of the PO2 in the histogram below the mean represented the second 
compartment oxygen tension. 
6. Other variables validated were arterial hemoglobin saturations, venous 
hemoglobin saturations and capillary PO2. But very scarce experimental data 
were available for validation of these variables. 
 The figures showing the validation of model predicted values to the 
experimental measured values for oxygen tension and coronary venous PO2 are 
shown in Figures 4.1- 4.3. It can be seen from the figures that the model is fairly 
capable of predicting the experimental values using a standard parameter set. This set 
shall be used for simulating various experimental strategies in the Results Section. 
For a human subject weighing 70 kg, 1.75 m tall and 30 years old, the predicted 
steady state cardiac tissue and blood oxygen tensions during normoxia (arterial PO2 = 
99 Torr) are tabulated in Table 3.10 
 
3.8 Algorithms 
In order to determine the partial pressure of oxygen (PO2), partial pressure of 
carbon monoxide (PCO) and O2 flux in each blood compartment of the model, it is 
necessary to solve three simultaneous algebraic equations   
 
 1. Oxyhemoglobin dissociation curve (Section 2.2, chapter 2). 
 2. Haldane’s equation (Section 2.2, chapter 2). 
 3. Blood to Tissue oxygen flux equations (Section 3.1.2, chapter 3). 
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The solutions for these equations were obtained by using algorithms based on 
gradient search methods which were developed for the modified model. An additional 
algorithm is also developed (bisection halving) to determine the PO2 corresponding to 
the average O2 concentration in the blood compartment. The technique used is a 
closed domain bracketing method and the root is trapped in the interval using interval 
halving (bisection) method. In this algorithm, two estimates for the root (x= PO2) are 
passed as arguments, which are generally the inlet (PO2max) and outlet (PO2min) 
variables ( blood O2 tension, tissue O2 tension, total concentration of O2, volume of 
blood or the tissue etc) of the blood vascular subcompartments. Now the root, x= PO2 
lies in the interval (PO2max , PO2min). The interval is systematically reduced based 
on the evaluate function decision and the error criterion, €. The algorithm for the 
search technique is shown in Figure 3.9. 
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Table 3.1: Prediction Equation for Estimating Volumes of Muscular Regions (Arms, 
Legs and Trunk) for Males and Females 
 
 
 
 
 
 
 
 
        
Table 3.2: Blood flow and Oxygen Consumption Values for Muscular Regions 
 
 
 
 
 
 
 
Region Volume in Men Volume in Women  
Leg (46.63* Vm)/100 (49.53* Vm)/100 
Arm (15.64* Vm)/100 (13.96* Vm)/100 
Trunk (37.73* Vm)/100 (36.51* Vm)/100 
Muscular 
Region 
Blood  Flow 
(ml/min/g)  
Oxygen consumption 
(ml/min/g) 
Arm 0.021 0.0014 
Leg 0.03 0.002 
Trunk 0.03 0.002 
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Table 3.3 : Cardiac Compartment Variables and Description 
 
Parameter Description 
.
cmQ  Blood flow to the myocardium 
SO2 Solubility of oxygen in plasma 
DcmO2 Diffusion coefficient of O2 between the two tissue subcompartments 
Dxcm Intercapillary distance 
Dcm CO  Diffusion coefficient of CO  between the two tissue subcompartments 
Blood Subcompartment 1 
Ccmv1O2 Concentration of O2 in the blood compartment 1 
CarO2 O2 concentration of arterial blood entering the blood compartment 1 
O2Fluxcm1 Rate of O2 diffusion out of the blood compartment 1 
PScmav Permeability surface area product for arterioles and venules 
Dbcm1O2 Blood to tissue diffusion coefficient 
Vcm1 Volume of the cardiac tissue compartment 1 
Ccmv1CO Concentration of CO in the blood compartment 
CarCO CO concentration of arterial blood entering the blood compartment 1 
COFluxcm1 Rate of CO diffusion out of the blood compartment 1 
ParCO Partial pressures of CO in the arterial blood compartment 
Pcmv1CO Partial pressures of CO in the blood vascular subcompartment 1 
Blood Subcompartment 2 
Vcm2 Volume of the cardiac tissue compartment 2 
Ccmv2O2 Concentration of O2 in the blood compartment 2 
O2Fluxcm2 Rate of O2 diffusion out of the blood compartment 2 
PScap Permeability surface area product of capillaries 
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Table 3.3: Cardiac Compartment Variables and Description (Continued) 
Parameter Description 
Ccmv2CO Concentration of CO in the blood compartment 2 
COFluxcm2 Rate of CO diffusion out of the blood compartment 2 
Pcmv2CO Partial pressures of CO in the blood vascular subcompartment 2 
Blood Subcompartment 3 
Ccmv3O2 Concentration of O2 in the blood compartment 3 
O2Fluxcm3 Rate of O2 diffusion into the blood compartment 2 
Ccmv3CO Concentration of CO in the blood compartment 3 
COFluxcm3 Rate of CO diffusion into the blood compartment 2 
Pcmv3CO Partial pressures of CO in the blood vascular subcompartments 3 
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Table 3.4: Myoglobin Concentration of the Heart. Concentrations of myoglobin were 
measure by BNII nephelometer technique in various regions of the human heart. The 
values were reported by CJM Joost et al ( Am J Clin pathol 2001:115:770-777) 
 
 
 
 
 
 
 
 
 
 
Region Mb Value 
(g/gm wet wt) 
Right ventricle 1.9 
Right atrium 1.0 
Left ventricle 2.4 
Left atrium 0.8 
Left ventricle 2.4 (0.25-11.7) 
Posterior wall 2.4 (0.78-4.05) 
Lateral wall 2.5 (0.67-5.21) 
Anterior wall 2.2 (0.38-11.7) 
Septum 2.4 (0.25-3.69) 
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Table 3.5: Physiological Cardiac Parameters 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Description and references Value 
DBVcm_on Fraction of blood that allows gas exchange with 
tissue compartment 1 (Section 3.6) 
0.095 
rho Density of cardiac muscle (35) 1.04 (gm/cm3) 
KcmO2 Michales-Menton coefficient of cardiac muscle(35) 0.2 
DXcm Intercapillary distance in cardiac muscle 
(Section 3.6) 
0.0353(cm) 
PScm_cap Permeability surface area product of O2 for capillaries 
(Section 3.6) 
450( ml/min/Torr/gm  ) 
PScm_av Permeability surface area product of O2 for 
arterioles/venules (Section 3.6) 
180( ml/min/Torr/gm  ) 
ConcMgb Concentration of myoglobin (Mb) 
(Table 3.4) 
0.0023 ( mg/g wet wt. 
muscle) 
Vcm Volume of heart  (L Reiner, 1959) 254(M),180(F) (gm) 
Vlv Volume of left ventricle (75) 94(M), 67(F) (gm) 
Vrv Volume of right ventricle (75) 46(M), 33(F) (gm) 
Va Volume of atria (75) 49(M), 39(F) (gm) 
Viv Volume of intra ventricular septum (75) 64(M), 49(F) (gm) 
Volfraccm Distribution fraction of blood volume to the tissue (A 
Indermuhle,2006) 
0.1161(ml/gm) 
FVcm Fraction of muscle volume in comp. around arteriole 
and venial blood comp.(Section 3.6) 
0.2 
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Table 3.6: Model -Derived Parameters 
 
 
 
 
Parameter Description Value 
Vcm1 Volume of cardiac muscle in compartment 1 perfused by 
arterioles/venules 
FVcm.Vcm 
Vcm2 Volume of cardiacmuscle in compartment 2 perfused by 
capillaries 
(1.-FVcm).Vcm 
MRO2cm Metabolic rate (MR) of O2 of cardiac muscle tissue Refer  Section 3.5.1 
MRO2_cm1 MR of O2 of skeletal muscle tissue 1 MRO2cm.Vcm1/(Vcm1+Vc
m2) 
MRO2_cm1 MR of O2 of skeletal muscle tissue 2 MRO2cm.Vcm2/(Vcm1+Vc
m2) 
Qdotcm Blood flow to the cardiac muscle tissue 2.18 . (HR) – 27.3 
DcmCO Cardiac Muscle diffusion coefficient for CO DMCO.(Dbcm2O2/DbMO2) 
Vbcm Volume of blood in cardiac compartment Volfraccm.Vcm 
Vbcm1 Blood volume of cardiac blood compartment 1 (Fvcm.Vbcm) -Vbcm3 
Vbcm2 Blood volume of  cardiac blood compartment 2 (1.0-Fvcm).Vbcm 
Vbcm3 Blood volume of  cardiac blood compartment 3 Fvcm.Vbcm .Dbvcm_on 
DcmO2 Inter-cardiac tissue diffusion coefficient of O2 60.DO2.10. 
DcmCO Intercardiac tissue diffusion coefficient ofCO fac.DcmO2 
Dbcm1O2 Diffusion coefficient of O2 from blood compartment 1 to 
cardiac tissue compartment 1; 
PScm_av.SO2.Vtm1/rho 
Dbcm2O2 Diffusion coefficient of O2 from blood compartment 2 to 
cardiac tissue compartment 2; 
PScm_cap.SO2.Vtm2/rho 
DcmCO_1 Diffusion coefficient of O2 from blood compartment 1 to  
cardiac  tissue compartment 2 
(Dbm1O2/Dbm2O2).DcmCO 
DcmCO_2 Diffusion coefficient of O2 from blood compartment 2 to  
cardiac  tissue compartment 2 
DcmCO 
DcmCO_3 Diffusion coefficient of O2 from blood compartment 2 to  
cardiac  tissue compartment 3 
DMCO_3.(Dbvcm1o2/Dbv
m1o2) 
fac Diffusion coefficient. for CO in tissues is 75% of O2 
diffusion coefficient 
0.75 
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Table 3.7: Simulation Parameters  
 
Parameter Description Value 
PbO2wi Atmospheric pressure during CO exposure  Simulation specific 
Pbo2wo Atmospheric pressure during treatment  Simulation specific 
TW Time by which the model reached steady state.  12 minutes 
COcm0pc Initial %CO in cardiac compartment(cpt) Subject specific (%) 
COcvm0pc Initial %CO in cardiac venous cpt. Subject specific (%) 
Gmix_cm O2 mix gain of cardiac tissues 1 
CINT Time step of the integration algorithm 0.001 
Tmax Maximum time of the simulation Simulation specific 
IALG Integration algorithm used 8(Runge kutta Fehlberg) 
Tzss, Tco Time at which CO exposure begins (or is present) 
in the simulation 
Simulation specific 
COppm Concentration of CO in part per million Simulation specific 
VdotWI Ventilation at the time of CO exposure Subject specific 
VdotWO Ventilation at the time of treatment Subject specific 
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Table 3.8: Sensitivity Analysis of the Parameters 
 
Parameter Variation Tissue PO2_1 Tissue PO2_2 Venous PO2 
O2 consumption ↑ 50% ↓ ↓ ↓ 
Mro2cm ↓ 50% ↑ ↑ ↑ 
Blood Flow ↑ 50% ↑ ↑ ↑ 
Q.cm ↓ 50% ↓ ↓ ↓ 
PS product  90 21.78 22.05 20.76 
Pscm_av 270 44.7  20.98  20.74 
PS product  225 37.97 12.711 20.86 
Pscm_cap 675 39.38  24.47 20.73 
AV Shunt fraction 0.0475 40.34 21.69 20.74 
Dbvcm_on 0.1425 37.86      21.28 20.74 
Volume distribution 0.1 49.52  23.25 20.74 
fvcm 0.3 32.45  19.98 20.7 
 
 
 
 
Table 3.9: Values for Standard Set  Table 3.10: Steady State Values 
of  parameters    in   human 
         
   
 
                                                                                                        
 
Parameter Value 
Pscm_av 180 
Pscm_cap 450 
Dbvcm_on 0.095 
fvcm 0.2 
Dxcm 0.0353 
Parameter Value(torr) 
PCM1O2 39 
PCM2O2 21.47 
PCMV1O2 50.91 
PCMV2O2 20.23 
PCMV3O2 20.74 
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Figure 3.1: Modified Model. The model consists of lungs, arterial and mixed venous 
blood, non-muscle tissue and two subcompartments within the muscle tissue. (Bruce, 
Bruce, Erupaka) 
 
(Figure also referred in Section 3.2) 
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Figure 3.2: Final Model. The model consists of lungs, arterial and mixed venous blood, 
non-muscle tissue, two subcompartments within the muscle tissue and the cardiac 
compartment with two subcompartments. 
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Figure 3.3: Cardiac Output and Carboxyhemoglobin. Figure shows the plot of the data 
(o) used (68,69,70) to build the relationship and  the  predicted data (*). The percent 
increase in carboxyhemoglobin levels of blood,  %∆COHb is plotted on the x-axis and  
the percent increase in cardiac output, %∆Q• on the Y-axis. Test data points (o) were 
considered from experiments whose data were not included in building the relation to 
check with the values (o) obtained from the predictor equation. 
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Figure 3.4 : Two Subcompartment Cardiac Tissue. The figure shows the two cardiac 
tissue compartments -1, 2 and the three cardiac blood compartments -1, 2, and 3 
surrounding the cardiac tissue. 
 
 
 
 
Figure 3.5: Vasculature of Cardiac Compartment. The tissue compartment 1 is 
assumed to be perfused by small arterioles (a) and small venules (v), as well as by 
capillaries The tissue compartment 2, is perfused mostly by capillaries (Ca, Cv). 
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Figure 3.6: Strategy for Developing Prediction Equations for the Model 
 
 
 
 
 
 
 
 
Collect HUMAN data from various journals for 
1. Myocardial oxygen consumption 
2. Myocardial blood flow 
3 Heart Rate 
Exclude data with measurement limitations like myocardial blood flow 
measured using Nitrous oxide dilution method had many limitations 
which tented to underestimate the myocardial blood flow prediction. 
Tabulate and plot the data 
 
Perform regression analysis 
Choose statistically significant prediction and validate it for 
data set not used to build the relation 
Implement the relation into the model 
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Figure 3.7: Heart Rate and Myocardial Blood Flow. Figure shows the plot of the data 
(o) used to build the relationship (79) and predicted data (*).The heart rate is plotted 
on the x-axis and the myocardial blood flow is plotted on the y-axis.  Test data points 
(o,o) were considered from experiments whose data (161) were not included in 
building the relation to check with the values(*,*) obtained from the predictor 
equation. 
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 Figure 3.8: Heart Rate and Myocardial Oxygen Consumption. Figure shows the plot 
of the data (o) used to build the relationship (80-86) and predicted data (*).The heart 
rate is plotted on the x-axis and the myocardial oxygen consumption is plotted on the 
y-axis. Test data points (o,o) were considered from experiments whose data was not 
included in building the relation to check with the values(*,*) obtained from the 
predictor equation. 
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Figure 3.9: Flow chart for the Algorithm 
 
 
 
 
 
 
 
 
 
 
 
Start with interval (a=PO2max , b=PO2 min ) 
c = (PO2max +PO2 min)/2 
x=c 
END 
Compute f(a)f(c) 
Continue iteration 
until a-b≤ € 
a=a 
b=c 
(a,c) 
a=c 
b=b 
(c,b) 
Compute  f(a)f(c) 
 
  <0     >0 
        
       =0 
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CHAPTER 4 
 
Results 
 
Chapter 4 presents both the validation results for the cardiac 
compartment and model predictions of extravascular burden of CO, and the 
resulting PO2 levels, for various simulations. This chapter describes the 
simulation conditions in detail like the inputs to the model, levels of CO 
exposures, time of CO exposure, type of treatment (room air or 100% O2) and 
data source etc. Also in this chapter, model predictions are graphed and 
tabulated for various experimental conditions that were simulated using the 
developed model.  
The final model (Figure 3.2) is used for validating the cardiac compartments 
and for all other simulations listed below. The validation protocol for the 
cardiac compartment has already been described in Section 3.7 of Chapter 3. 
Predictions from the model were compared with published observations on 
human subjects and animal data (Table 4.1). The model of the cardiac 
compartment is validated for conditions of hypoxia, exercise and hyperoxia.  
 
4.1 Model Validation 
Model predictions for the blood and tissue PO2 were compared with 
experimentally measured values from various experiments reported in the 
literature (Table 4.1). These variables (myocardial tissue and blood PO2) were 
evaluated for conditions of hypoxia, hyperoxia and exercise in the absence of 
CO. Most of the available experimental data are from anesthetized animal 
studies. Figure 4.1, Figure 4.2, and Figure 4.3 show the comparison of model 
predictions (myocardial tissue and coronary venous PO2) with experimentally 
measured values.   From Figure 4.1 it can be seen that the model predictions 
of coronary venous tend to overestimate the coronary venous PO2 when 
compared to the experimental data reported in the literature. The model 
estimates are ~34.7% greater than the experimentally measured coronary 
venous PO2 values. Figure 4.2 shows the comparison of model predictions of 
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myocardial tissue PO2 in subcompartment 1 with experimentally measured 
myocardial tissue PO2 (measurement sites close to arterioles or generally a 
large electrode or the average value of the upper half of PO2 histograms was 
used). The model predictions of the first compartment tissue PO2 match well 
with the experimentally measured values reported in the literature. However, 
at lower experimental PO2 the model tends to slightly overestimate the 
predicted PO2’s. In Figure 4.3, comparison of model predictions of 
myocardial tissue PO2 in subcompartment 2 with experimentally measured 
myocardial tissue PO2 is shown. The experimental measurement made with 
electrodes whose size is comparable to that of a capillary and the average 
value of the lower half of PO2 histograms was assumed to represent the tissue 
PO2 in the second compartment. The predictions made by the model for 
myocardial tissue PO2 of subcompartment 2 slightly underestimate the 
experimentally made measurements by 28.37%. At very low experimentally 
measured PO2’s, the model predicts negative tissue PO2. Values of certain 
parameters like PS (permeability surface area product) and FVcm (volume 
distributing fraction of cardiac compartment) were determined to best fit the 
model predictions with the experimental data. Thus, model validation also 
helped to determine the values (Section 3.6) for some parameters.  
 
  4.2 Model Simulations 
 The major goal of the thesis was to predict myocardial MbCO 
levels and tissue PO2 levels (extravascular burden) during CO exposures and 
treatment sessions. Estimating the extravascular burden of CO on the heart 
will aid in understanding the severity of myocardial tissue hypoxia during (or 
after) CO poisoning. The various simulations done below explain the data 
source, experiment protocol, relevance of simulation, inputs to the model 
available (provided by the investigators of the experiment), model parameters 
determined, and predictions of extravascular burden of CO on heart and 
coronary venous PO2 (outputs). In all the simulations extravascular 
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(myocardial tissue PO2 and MbCO) burden of CO on human heart is 
predicted. The following simulations have been analyzed in this thesis: 
1. Simulation of short-high concentration CO exposure. 
2. Simulation of long-low concentration CO exposure. 
3. CO rebreathing during 100% O2 administration. 
4. CO exposure during Rest and Exercise Sessions 
  
 
4.2.1 Short Duration-High Concentration CO Exposure: 
 
Data Source for the Simulation: Subject 120, Reference 154. Benignus et.al 
exposed human subjects to high concentration of CO (6683 PPM) during 
room air breathing for 4-6 Minutes, followed by washout on air for 4-5 hrs.  
 
Experiment Protocol:  
            
Tw = Time for the model to reach a steady state (12 min) 
TCO= Start time of CO exposure 
TRA= Start time for treatment with room air 
Tend = End time of simulation 
 
Simulation Relevance: This kind of simulation would find relevance when 
trapped for 5-10 mins in a house or a coal mine which is on fire, or in a car 
with its exhaust blocked. 
 
   T=0        TW TCO    TRA                                 Tend 
5min 283 mins 
6683 ppm 
12min 
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Parameters Provided by Investigators: age, gender, height, body weight, 
concentration of CO, hemoglobin concentration in blood, barometric pressure, 
temperature, cardiac output , ventilation, volume of blood, exposure and 
treatment times, room air treatment, HbCO levels in radial artery and 
antecubital vein sampled every minute for the first 6  min, then intermittently 
thereafter.   
 
Parameters Determined:  Total body O2 consumption (233 ml/min/Kg), heart 
rate (Section 3.5.3), ventilation adjusted, diffusion coefficient for CO (Bruce, 
Bruce and Erupaka), myocardial blood flow (Section 3.5.1), myocardial O2 
consumption (Section 3.5.1), increases in cardiac output  (Section 3.2.4) and  
increases in heart rate (Section 3.5.3) with increases in blood HbCO levels. 
These parameters are the values determined from regression relationships or 
from the literature. 
 
Model Predictions: Figure 4.4 shows the predicted HbCO levels in arterial 
blood, coronary venous partial pressure of O2 (PcvO2), oxygen tension in 
cardiac subcompartment 1 (Pcm1O2), MbCO levels in cardiac 
subcompartment 1 (MbCOcm1), oxygen tension in cardiac subcompartment 2 
(Pcm2O2) and MbCO levels in cardiac subcompartment 2 (MbCOcm2). The 
values of the predicted variables are as shown below: 
 
 
 
Variable 
Values before begin 
of CO Exposure 
Values at End of 
CO Exposure 
Values at End of 
Treatment 
% HbCO 0.73 14.17 6.19 
%MbCOcm1,%MbCOcm2 0.25,  0.32 5.39, 7.38 2.34, 3.08 
Pcm1O2, Pcm2O2(Torr) 36.52, 19.33 21.45, 13.26 36.01, 21.08 
PcvO2  (Torr) 19.06 12.84 16.46 
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 As seen in Figure 4.4 MbCO levels in compartment 2 are higher than in 
compartment 1, resulting in a lower tissue PO2 in compartment 2 after CO 
exposure. The HbCO level in arterial blood increases, resulting in increased 
cardiac output. Increase in cardiac output is achieved by increased myocardial O2 
consumption accompanied with increase in myocardial blood flow. More CO load 
is delivered to the tissues due to increase in blood flow to the tissue. Also, the 
myocardial O2 consumption increases and the tissue PO2 falls resulting in higher 
MbCO levels. Figure 4.5 shows comparison of the MbCO levels and tissue PO2 of 
resting skeletal muscle and cardiac muscle tissues for the same CO exposure 
protocol. It can be seen from the Figure 4.5 that the MbCO levels are lower and 
the tissue PO2 are greater in skeletal muscle than that of cardiac muscle. Lower 
MbCO levels in resting skeletal muscle are due to lower oxygen consumption, 
lower blood flow, less CO load delivered and higher PO2 than that of cardiac 
muscle, which is a rigorously working muscle. The values for the resting skeletal 
muscle are as shown below  
 
 
4.2.2 Long Duration-Low Concentration CO Exposure 
 
Data Source for the Simulation: The same parameters used in section 4.2.1 
were used for this simulation. But the experiment protocol is different for this 
simulation. Subject 120 is exposed to 90 ppm of CO for a period of 8 hrs. 
There is no treatment in this protocol. 
Variable Values before 
begin of CO 
Exposure 
Values at End 
of CO 
Exposure 
Values at End of 
Treatment 
% HbCO 
6.19 0.73 14.1
7 
%MbCOcm1,%MbCOcm2 
1.99,  2.05 0.39,  0.48 2.3, 1.57 
Pm1O2, Pm2O2 (Torr) 42.03, 
27.75 
35.9,  22.16 39.16, 
25.09 
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Simulation Relevance: This kind of simulation would find relevance when 
there is a faulty heater at work place or a faulty furnace at home.  
 
Experiment Protocol:  
      
Model Predictions: Figure 4.6 shows the predicted HbCO levels, coronary 
venous PO2, PcvO2, MbCO levels, MbCOcm1 and MbCOcm2 and myocardial 
oxygen tensions, Pcm1O2 and Pcm2O2,. The predicted values before CO 
exposure are similar to the values of the simulation above (Section 4.2.1). 
Simulating this experimental protocol would help to understand the impact of 
CO load on the heart for a greater length of time and its resulting effect on the 
myocardial O2 tension. Concentration of CO exposure is lower in this 
simulation but is present for a greater length of time. The HbCO levels in 
blood reach ~9.6% resulting in MbCO levels of 3.84% and 5.24% in cardiac 
subcompartments 1 and 2. The tissue PO2 in the first subcompartment is 32 
Torr, which is a reasonable PO2 however, the tissue PO2 is slightly lower in 
the subcompartment 2 (which is a major subcompartment of the heart model) 
for a long duration of time, resulting in tissue hypoxia. If the duration of CO 
exposure or concentration of CO would be increased, then the cardiac tissue 
would be O2 impaired for longer duration of time resulting in imbalance of 
homeostasis of O2 delivery and metabolism of heart. The values of the 
predicted variables are as follows: 
Variable Values at End of CO 
Exposure 
% HbCO 9.5904 
% MbCO 3.84, 5.24 
Tissue PO2 (Torr) 32, 15.12 
Cardiac Venous Po2  (Torr) 14.91 
   T=0          TW  TCO                Tend 
480 mins 
  90 ppm 
12min 
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4.2.3 CO Rebreathing During 100% O2  Administration 
 
Data Source for the Simulation: Subject 1, Reference 155. Burge & Skinner 
had conducted CO rebreathing experiments in hyperoxia (100% O2) to 
estimate the total blood volume. Subjects in this study rebreathed 60-70ml of 
CO for a period of 40 mins while breathing 100% oxygen.   
 
Simulation Relevance: This method is a standard one used for determining 
total blood volume of a subject.  Also, the closed breathing design of the 
experiment helps in estimating the blood-to-tissue diffusion coefficient of CO 
(35) because the slow decrease in %HbCO after 10 min is sensitive to this 
coefficient.  
 
     Experiment Protocol:  
 
TO2= Start time for treatment with 100% O2 
 
Parameters Provided by Investigators: age, gender, height, body weight, 
injected volume of CO,  barometric pressure, temperature, volume of blood, 
exposure and hyperoxia breathing times, and volume of the rebreathing 
circuit.   
 
Parameters Determined:  Total body O2 consumption (233 ml/min/kg), 
cardiac output (Section 3.5.2), heart rate (Section 3.5.3), ventilation is 
assumed to be 0 during rebreathing, diffusion coefficient for CO (Bruce, 
Bruce and Erupaka),  myocardial blood flow (Section 3.5.1), myocardial O2 
   T=0        TW ( TO2 ,TCO  )                                      Tend 
40 mins 
  70 ml 
12min 
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consumption (Section 3.5.1), increases in cardiac output  (Section 3.2.4) and  
increases in heart rate (Section 3.5.3) with increases in blood HbCO levels 
The parameters during 100% oxygen breathing are not known. Regression 
equations developed for determining parameters during normoxia were 
applied for predicting cardiac ouput, heart rate etc., during hyperoxia.  
 
Model Predictions: Figure 4.7 shows the predicted HbCO and MbCO levels in 
arterial blood and tissue subcompartments, coronary venous partial pressure of 
O2 (PcvO2) and  myocardial oxygen tensions. MbCO levels of 
subcompartment 1 are greater by 2% than the subcompartment 2 during the 
intial 5-6 mins of the experiment and then the MbCO levels in the two 
subcompartments reach equilibrium. The tissue PO2 falls approximately by 46 
Torr in the subcompartment 1  and 7 Torr in the subcompartment 2. However 
after the end of CO exposure, the tissue PO2 of cm1 increases approximately 
to 92 (close to value before CO exposure) Torr, and the PO2 of cm2 increases 
to 20.31 Torr. However the tissue PO2 in cm2 does not increases as much as 
expected during 100% O2 breathing. This could be due to errors in 
determining the parameters during treatment protocol.  The values of the 
predicted variables are as follows: 
 
 
 
 
 
 
 
  
4.2.4 CO Exposure During Exercise 
 
Data Source for the Simulation: Subject 21, Reference 69. Kizakevitch 
et al. conducted experiments where the subjects performed lower body 
Variable 
Values before begin 
of CO Exposure 
Values at End of 
CO Exposure 
% HbCO 1.07 10.94 
%MbCOcm1,%MbCOcm2 1.07, 0.92 3.96, 3.56 
Pcm1O2, Pcm2O2(Torr) 96.4, 22.56 50, 17.3 
PcvO2  (Torr) 23.29 17.07 
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exercise using a treadmill.  Subjects underwent air exposures at their base 
level HbCO (0-2%) and CO exposures to fours levels of HbCO (5%, 10%, 
15%, 20%). At each level of HbCO, subjects underwent exercise sessions 
comprised of rest and three 5 min exercise periods (R, E1, E2, E3). The 
exercise intensity was increased in a step wise fashion and the experiment was 
conducted over two days.  
 
Simulation Relevance:  Working groups exposed to CO concentrations higher 
than the permissible levels are more susceptible to severe tissue hypoxia 
because increased work increases the oxygen demand in the tissue, but CO 
interferes with O2 delivery by binding to hemoglobin. Myoglobin 
functionality is also impaired as CO binds to myoglobin, further impairing O2 
availability.  Predicting tissue oxygenation and MbCO levels in the cardiac 
compartment during CO exposures will estimate the extent of tissue hypoxia 
in the heart. 
 
Parameters Provided by Investigators: age, gender, height, body weight, 
concentration of CO in inspired air (1000 ppm for 5% HbCO, 3000 ppm for 
10%, 15% and 20% HbCO levels. 27 ppm, 55ppm, 83ppm and 100 ppm were 
used to maintain HbCO concentrations at 5%, 10%, 15% and 20% 
respectively),  total body metabolic rate, ventilation , cardiac output, heart 
rate, times for begin of exercise stages and time of 100% O2 exposure.  
 
Experiment Protocol:   
The protocol the authors followed was as follows: 
E = Exercise; R= Rest 
Day 1: Baseline HbCO (R, E1, E2, E3) - 5% HbCO(R, E1, E2, E3) - 
15% HbCO – (R, E1, E2, E3)- Administer 100% O2 
Day 2: Baseline HbCO (R, E1, E2, E3) - 10% HbCO(R, E1, E2, E3) - 20% 
HbCO – (R, E1, E2, E3) - Administer 100% O2. 
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Parameters Determined: Diffusion coefficient for CO (2.5 ml/min/Torr), 
myocardial blood flow (Section 3.5.1), myocardial O2 consumption (Section 
3.5.1), blood volume, ventilation adjusted to maintain normoxic arterial PO2, 
cardiac output (Section 3.5.2,3.5.3) and heart rate during O2 administration . 
 
 
       
Model Predictions:  
 
4.2.4.1 Baseline HbCO (1.9%) at Rest and Three Levels of Exercise: 
(Figure 4.8). Myocardial tissue and venous PO2 decrease from rest in a 
stepwise fashion with exercise stages 1 and 2. At the beginning of exercise 
stage 3, the PO2 in the myocardial tissue and blood subcompartments 
increase. The MbCO levels in the subcompartments increase but are 
insignificant. There is a significant decrease in tissue PO2 (decreases by 10 
Torr and 6 Torr, respectively) of cm1 and cm2 at the end of exercise stage 2. 
There is an increase in tissue oxygen tensions during exercise stage 3. With 
increased exercise load one would expect the tissue PO2 to fall, but the tissue 
PO2 increases because the cardiac output increases by 2.6 times the resting 
value. Increase in cardiac output results in increased blood flow to the heart 
and there is more O2 available for delivery to the tissues. Also the HbCO 
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levels are minimal, resulting in noncompetitive binding of O2 with 
hemoglobin, there by resulting in increased tissue PO2. The values are  
 
Variables Rest Exercise 1 Exercise 2 Exercise 3 
% HbCO 1.9 1.9 1.9 1.9 
% MbCO 0.68, 0.87 0.73, 0.98 0.86, 1.24 0.73, 0.95 
Tissue PO2 (Torr) 34.26, 18.66 28, 15.8 24.43, 12.36 32.5, 18.2 
Cardiac Venous PO2 20.9 Torr 17.8 Torr 15.09 Torr 19.54 Torr 
 
4.2.4.2 HbCO (10%) at Rest and Three Levels of Exercise (Figure 4.9) 
The subcompartment MbCO levels increase with stages of exercise, though 
the HbCO levels are maintained at 10%. The PO2 (tissue and blood) in the 
cardiac subcompartments decrease and MbCO levels increase linearly till the 
constant HbCO levels of 10% are attained. There is a negligible increase 
noticed in MbCO levels during the 5 min rest period, followed by a steep 
increase during exercise stages 1 and 2 and then a linear increase during 
exercise stage 3.  
 
Variables Rest Exercise1 Exercise 2 Exercise 3 
% HbCO   9.94  10 9.97   10 
% MbCO 3.76, 5.09 4.12, 5.62 4.05 , 5.51 4.8, 7.1 
TissuePO2 
(Torr) 
32.03, 15.33   31.14, 14.15 31.22 , 14.17 25.15, 10.45    
Cardiac Venous 
Po2 
16.61 Torr 15.76 Torr 15.74 Torr 12.85 Torr 
 
 The tissue and blood PO2’s of heart decrease by 1-2 Torr initially during the 
rest session, then fall by few Torr and are maintained constant during stages 1 
and 2 of exercise. There is a significant drop of PO2 in tissue and blood 
subcompartments during exercise stage 3, especially in tissue subcompartment 
2. The heart rate during stage 3 increases approximately by 98% due to 
exercise and increase in blood HbCO levels. Increased heart rate  increases 
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myocardial O2 consumption and myocardial blood flow. Also the cardiac 
ouput increases due to exercise and CO exposure. This results in more CO 
load being delivered to the heart, as CO has more affinity than O2 to bind to 
hemoglobin. It results in higher MbCO levels and lower tissue PO2 in the 
subcompartments of the heart.   
 
4.2.4.3 HbCO (20%) at Rest and Three Levels of Exercise (Figure 4.10) 
The subcompartment MbCO levels increase with stages of exercise, though 
the HbCO levels are maintained at 20%. After reaching constant HbCO level 
of 20%, there is a step wise decrease in PO2’s (of myocardial tissue and blood 
subcomparments) with  exercise stages. There is a decrease of tissue and 
blood PO2 in the cardiac subcompartments with linear increase of tissue 
MbCO levels. There is a significant large drop in the oxygen tensions of tissue 
subcompartment 2 during exercise stage 1 and exercise stage 2 compared to 
exercise stage 3. The cardiac output increases by 81%, 102% and 119% 
respectively compared to the rest session at 20% HbCO levels. Increasing 
metabolic demand of O2 with exercise stages and poor tissue oxygenation due 
to increased CO load (due to increasing blood flow) results in PO2 of 3.7 Torr 
and 2.28 Torr. If these tissue PO2 persists for longer time, then the metabolic 
oxygen demands may be met with anaerobic metabolism. 
 
Variables Rest Exercise1 Exercise 2 Exercise 3 
% HbCO 19.78 19.73 19.7 19.6 
% MbCO 8.81, 12.74 11.07, 17.49 14.25, 25.25 18.75, 33.93 
TissuePO2 
(Torr) 
23.8, 10.29   20.03, 6.66   14.55, 3.71 9.19, 1.92 
Cardiac Venous 
Po2 
11.91 Torr 8.8 Torr 5.6 Torr 2.28 Torr 
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4.2.4.4 HbCO (20%) at Rest and Three Levels of Exercise Followed with 100% O2 
Treatment:  
After the third stage of exercise, the subject breathed 100% O2 for 60 mins 
(Figure 4.11). The model predictions at the end of 60 mins are as follows 
 
Variables Rest End of therapy 
% HbCO 1.9 13.78 
% MbCO 0.68, 0.87 6.97, 8.38 
TissuePO2 (Torr) 34.26, 18.66 108, 17 
Cardiac Venous Po2 20.9 Torr 18.45 Torr 
 
  100 % O2 breathing after CO exposure decreases the HbCO and MbCO levels in 
arterial blood and the cardiac tissue subcompartment (Figure 4.11). There is an 
increase in myocardial blood and tissue PO2’s with 100% O2 breathing. A 
significant increase in the tissue PO2 of cardiac subcompartment 1 is observed 
with 100% O2 breathing. However, the PO2 of tissue subcompartment 2 only 
increases to 17 Torr after 100% O2 breathing. The MbCO levels in cm2 are 8.38% 
after breathing 100% O2. The cardiac output for this session (breathing 100% O2) 
was determined from the predictive equation considering the total body O2 
consumption at rest (during 20% HbCO). Making this assumption may have 
effected the prediction for second compartment myocardial tissue PO2. The 
determined cardiac output may have been underestimated for the hyperoxia 
session which resulted in lower blood flow to the heart compartment. Also the 
MbCO levels were higher in the second compartment accompanied with lower 
blood flow during hyperoxia which resulted in lower tissue PO2 in cm2 at end of 
therapy (recovery) session. Figure 4.12 compares the model predictions for 
extravascular burden of CO (PO2 and MbCO) while breathing 100% O2 vs Room 
air after CO exposure. It can be seen from the figure that breathing 100% O2 after 
exposure shows higher tissue PO2 and lower MbCO levels than breathing room 
air.  
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4.2.4.5 Baseline HbCO (1.9%) - HbCO (5%) - HbCO (15%) (Each session at 
Rest and Three Levels of Exercise) Followed with 100% O2 Treatment.  
Figure 4.13 
There is a step wise decrease in PO2’s (of myocardial tissue and blood 
subcomparments) with exercise stages and increasing HbCO levels. There is an 
increase in myocardial blood and tissue PO2’s with 100% O2 breathing.  Also, the 
HbCO and MbCO levels in arterial blood and the cardiac tissue subcompartment 
decreases with 100 % O2 breathing after CO exposure. The responses of decreases 
in PO2 and increases in MbCO levels (of the cardiac subcompartments) are 
qualitatively similar to the exercise simulations discussed above for 10% and 20% 
HbCO levels but the values reach are quantitatively different as the current 
simulation involves lower HbCO levels of 5% and 15 % compared to 10% and 
20%. Thus we can expect that with increasing HbCO levels, the quantitative 
values attained may be different but the same qualitative response pattern may be 
followed. 
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Table 4.1 : Validation of the Model. 
R Species Exp
. 
Par
O2 
Model 
Par O2 
Exp. 
PcmvO
2 
Model 
PcmvO2 
Exp. 
PtO2 
Model 
Pcm1 O2 
Model 
Pcm2 O2 
Q ۠cm Mr 
O2c
m 
91 Human 99 98.98954 17.25 20.50 - 34.84992 19.69238 118 15 
91 Human 42 43.66366 15.75 12.96 - 16.6563 13.77764 167 17 
91 Human 36 36.9957 15 11.45 - 13.41558 12.40324 261 25 
157 Dog 92 91.76348 18.8 25.39 19.9 48.66612 29.18559   
157 Dog 92 91.76348 26 25.39 - 48.66612 29.18559 90 6.6 
45 Dog 32 32.05925 22 19.99286 - 23.1705 21.40628 160 9.79 
45 Dog 27 27.79234 18 19.91647 - 21.8324 20.94568 210 6.7 
96 Swine 103 103.4311 27.33 27.34 50 41.64232 27.36177 94 6.7 
96 Swine 57 57.94478 22.77 30.84952 35 40.77736 33.06806 129.7
2 
5.695 
96 Swine 44 44.08298 19.75 27.27827 26 30.6389 27.93219 147.5
8 
5.963 
96 Swine 189 190.4437 31.8 24.08567 - 59.21405 27.35737 125 11.3 
94 Swine 39 39.42103 21 17.97635 - 23.59683 19.52166 175 12.5 
94 Swine 40 40.54051 17 20.95588 - 26.80393 22.58181 173 9.8 
93 Dog 64.2 64.1 18.3 19.314 18.9 35.456 24.34   
93 Dog 326 325.36 - 20.93615 49/26 61.77243 23.12536 0.8 0.1 
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Table 4.1: Validation of the Model (Continued) 
R Species Exp
. 
Par
O2 
Model 
Par O2 
Exp. 
PcmvO
2 
Model 
PcmvO2 
Exp. 
PtO2 
Model 
Pcm1 O2 
Model 
Pcm2 O2 
Q ۠cm mr 
O2c
m 
93 Rat 99 100.1104 - 20.80742 40/20 42.32027 21.26861 4.5 0.54 
93 Rat 89 88.34195 - 20.24898 15/35 38.95486 19.60096 4.5 0.54 
94 swine 150 150.178 - 26.8742 30.3±
4.7 
59.84115 30.68439 94 6.7 
161 swine 150 150.178 - 26.8742 42±4 59.84115 30.68439 94 6.7 
95 Rat 99 100.094 - 20.685 48/18 41.1873 21.41581 4 0.4 
96 Dog 143 142.191 46 19.43323 42±7 47.515 21.56576 0.8 0.1 
97 swine 359 358.476 - 29.10781 112±
8.48 
77.4706 33.0111 94 6.7 
98 swine 90 90.4641 23.25 24.90368 46±7.
5 
47.8475 28.38637 94 6.7 
99 Rat 99 100.1104 - 20.80742 10 42.32027 21.26861 4.5 0.54 
44 swine 99 98.1135 - 25.2926 49±2 49.9177 28.86385 94 6.7 
100 Rat 87  20  25   233.1 39.6 
 
R= Reference, Exp.= Experimental,  ParO2 = Arterial PO2, PcmO2 =  Coronary Venous PO2, 
PtO2 = Cardiac Tissue PO2, Pcm1O2 =  Cardiac Subcompartment 1 PO2, Pcm1O2 =  Cardiac 
Subcompartment 1 PO2, Q۠cm= Myocardial Blood Flow, mrO2cm = Myocardial Oxygen 
Consumption. 
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Figure 4.1: Comparison of Coronary Venous PO2.  Comparison of model 
predictions of coronary venous PO2 (y-axis) with experimentally measured 
coronary venous PO2 (x-axis). (Table 4.1).  The dashed line represents the 
regression equation. 
 
Statistical Significance: 
Model Coronary Venous PO2 = 0.742 x Experimental Coronary Venous  PO2 + 
6.812 
Standard error of estimate: 3.566 
Regression coefficient, R: 0.743    
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Figure 4.2 : Comparison of Myocardial Tissue PO2 in Subcompartment 1.  
Comparison of model predictions of myocardial tissue PO2 (y-axis) in 
subcompartment 1 with experimentally measured (x-axis) myocardial tissue PO2 
(measurement sites close to arterioles or generally large electrode was used). 
(Table 4.1).  The dashed line represents the regression equation. 
 
Statistical Significance: 
Model Compartment 1 PO2 = 0.918 x Experimental Compartment 1 PO2 + 6.532 
Standard error of estimate: 6.387 
Regression coefficient , R: 0.643 
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Figure 4.3: Comparison of Myocardial Tissue PO2 in Subcompartment 2.  
Comparison of model predictions of myocardial tissue PO2 (y-axis) in 
subcompartment 2 with experimentally measured (x-axis) myocardial tissue PO2 
(measurements made with electrodes whose size is comparable to that of size of a 
capillary). (Table 4.1). The dashed line represents the regression equation. 
 
Statistical Significance: 
Model Compartment 2 PO2 = 1.396 x Experimental Compartment 2 PO2 -8.007 
Standard error of estimate: 2.803 
Regression coefficient , R: 0.913    
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        Figure 4.4: Prediction for Short Duration-High Concentration CO Exposure. 
Figure shows the predicted %HbCO levels in arterial blood, coronary venous 
partial pressure of O2 (PcmvO2), oxygen tension in cardiac subcompartment 1 
(Pcm1O2), MbCO levels in cardiac subcompartment 1 (%MbCOcm1), oxygen 
tension in cardiac subcompartment 2 (Pcm2O2) and MbCO levels in cardiac 
subcompartment 2 (%MbCOcm2) for a short (5min) CO exposure (6683 ppm). 
The point (•) shows the start of therapy (room air administration) at t = 5 min, 
lasting for 283mins after CO exposure. Simulation time is plotted on the x-axis 
and the model predicted variables are plotted on the y-axis.
PO2 in Torr HbCO and MbCO Levels in Percentile 
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Figure 4.5: Prediction Summary for Short Duration-High Concentration CO 
Exposure. Figure shows the predicted %HbCO (blue) levels in arterial blood, % 
MbCO levels in cardiac subcompartment 1 (red solid) and cardiac 
subcompartment 2 (red dashed), oxygen tension in cardiac subcompartment 1 
(green solid) and cardiac subcompartment 2 (green dashed); % MbCO levels in 
resting skeletal muscle subcompartment 1 (magenta solid) and resting skeletal 
muscle subcompartment 2 (magenta dashed), oxygen tension in skeletal muscle 
subcompartment 1  (cyan solid) and skeletal muscle subcompartment 2 (cyan 
dashed) for a short (5min) CO exposure (6683 ppm). Simulation time is plotted on 
the x-axis and the model predicted variables are plotted on the y-axis. 
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Figure 4.6 :Prediction for Long Duration-Low Concentration CO Exposure. 
Figure shows the predicted %HbCO levels in arterial blood, coronary venous 
partial pressure of O2 (PcmvO2), oxygen tension in cardiac subcompartment 1 
(Pcm1O2), MbCO levels in cardiac subcompartment 1 (%MbCOcm1), oxygen 
tension in cardiac subcompartment 2 (Pcm2O2) and MbCO levels in cardiac 
subcompartment 2 (%MbCOcm2) for a long (480min) CO exposure (90 ppm). 
The point (•) shows the start time of CO exposure. Simulation time is plotted on 
the x-axis and the model predicted variables are plotted on the y-axis. 
 
 
 
HbCO and MbCO Levels in Percentile PO2 in Torr 
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Figure 4.7: CO Rebreathing During 100% O2 Administration. Figure shows the 
predicted %HbCO (blue) levels in arterial blood, % MbCO levels in cardiac 
subcompartment 1( red solid) and cardiac subcompartment 2 (red dashed), 
coronary venous PO2 (blue solid) oxygen tension in cardiac subcompartment 
1(green solid) and cardiac subcompartment 2( green dashed) for a period 480 
mins with CO concentrations being 90ppm. The point (•) shows the start of CO 
exposure. Simulation time is plotted on the x-axis and the model predicted 
variables are plotted on the y-axis. 
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Figure 4.8:  Baseline HbCO (1.9%) at Rest and Three Levels of Exercise. Figure 
shows the predicted %HbCO levels in arterial blood, coronary venous partial 
pressure of O2 (PcmvO2), oxygen tension in cardiac subcompartment 1(Pcm1O2), 
MbCO levels in cardiac subcompartment 1(%MbCOcm1), oxygen tension in 
cardiac subcompartment 2(Pcm2O2) and MbCO levels in cardiac subcompartment 
2(%MbCOcm2. The points (•) show the end times of 5 min sessions of rest, 
exercise 1, exercise 2 and exercise 3. The sessions are simulated at baseline 
HbCO levels of 1.9%. Simulation time is plotted on the x-axis and the model 
predicted variables are plotted on the y-axis.   
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Figure 4.9 : HbCO (10%) at Rest and Three Levels of Exercise. Figure shows the 
predicted %HbCO levels in arterial blood, coronary venous partial pressure of O2 
(PcmvO2), oxygen tension in cardiac subcompartment 1(Pcm1O2), MbCO levels 
in cardiac subcompartment 1(%MbCOcm1), oxygen tension in cardiac 
subcompartment 2(Pcm2O2) and MbCO levels in cardiac subcompartment 
2(%MbCOcm2. The points (•) show the start times of 5 min sessions of rest, 
exercise 1, exercise 2 and exercise 3. The sessions are simulated at baseline 
HbCO levels of 10%. Simulation time is plotted on the x-axis and the model 
predicted variables are plotted on the y-axis.  
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Figure 4.10 : HbCO (20%) at Rest and Three Levels of Exercise. Figure shows 
the predicted %HbCO levels in arterial blood, coronary venous partial pressure of 
O2 (PcmvO2), oxygen tension in cardiac subcompartment 1(Pcm1O2), MbCO 
levels in cardiac subcompartment 1(%MbCOcm1), oxygen tension in cardiac 
subcompartment 2(Pcm2O2) and MbCO levels in cardiac subcompartment 2 
(%MbCOcm2).The points (•) show the start times of 5 min sessions of rest, 
exercise 1, exercise 2 and exercise 3. The sessions are simulated at baseline 
HbCO levels of 20%. Simulation time is plotted on the x-axis and the model 
predicted variables are plotted on the y-axis.    
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Figure 4.11: HbCO (20%) at Rest and Three Levels of Exercise Followed with 
100% O2 Treatment. Figure shows the predicted %HbCO levels in arterial blood, 
coronary venous partial pressure of O2 (PcmvO2), oxygen tension in cardiac 
subcompartment 1(Pcm1O2), MbCO levels in cardiac subcompartment 
1(%MbCOcm1), oxygen tension in cardiac subcompartment 2(Pcm2O2) and 
MbCO levels in cardiac subcompartment 2(%MbCOcm2).The points (•) show the 
end times of 5 min sessions of rest, exercise 1, exercise 2, exercise 3 and start 
time of 100% O2 breathing for period of 60 mins. The sessions are simulated at 
baseline HbCO levels of 20%. Simulation time is plotted on the x-axis and the 
model predicted variables are plotted on the y-axis.  
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Figure 4.12: Comparison of 100% O2 and Room Air breathing after CO 
exposure. Comparison of 100% O2 VS. Room Air Treatment During 20% HbCO 
at Rest and Three Levels of Exercise: Figure shows the predicted %HbCO levels 
in arterial blood, coronary venous partial pressure of O2 (PcmvO2), oxygen 
tension in cardiac subcompartment 1(Pcm1O2), MbCO levels in cardiac 
subcompartment 1(%MbCOcm1), oxygen tension in cardiac subcompartment 
2(Pcm2O2) and MbCO levels in cardiac subcompartment 2(%MbCOcm2).The 
points (•) show the start times of 5 min sessions of rest, exercise 1, exercise 2, 
exercise 3 and start time of 100% O2  (blue) or room air (red)  breathing for 
period of 60 mins. The sessions are simulated at baseline HbCO levels of 20%. 
Simulation time is plotted on the x-axis and the model predicted variables are 
plotted on the y-axis. 
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Figure 4.13: Baseline HbCO (1.9%) - HbCO (5%) - HbCO (15%) (Each session 
at Rest and Three Levels of Exercise) Followed with 100% O2 Treatment. Figure 
shows the predicted %HbCO (blue) levels in arterial blood, % MbCO levels in 
cardiac subcompartment 1( red solid) and cardiac subcompartment 2 (red dashed), 
oxygen tension in cardiac subcompartment 1 (green solid) and cardiac 
subcompartment 2 ( green dashed).  The point (•) shows the 5 min end time 
session of rest (-), exercise 1(--), exercise 2 (-.-.-) and exercise 3 (….). The HbCO 
level attained are 1.9%, 5% and 15%. Simulation time is plotted on the x-axis 
and the model predicted variables are plotted on the y-axis. 
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CHAPTER 5 
Discussion 
 
This chapter summarizes the modifications made to the selected primary model 
(Figure 2.1), and discusses the limitations of the current model, issues related to 
parameter estimations, and concerns regarding the model validation and results. 
 
The most essential step in modeling is to determine the exact need for the 
model. In this thesis we need the model to predict the amount of CO entering the 
blood and the cardiac tissues and to determine the effects of CO on tissue 
oxygenation (PcmO2, tissue PO2 of the cardiac compartment). Uptake of CO by blood 
can be determined by measuring the COHb levels in the venous blood. But it is 
difficult to measure MbCO (carboxymyoglobin) levels and tissue PO2 in the human 
heart noninvasively. It is not expected from the model that the predictions be literally 
true but one can insist that the models provide useful approximations and their 
usefulness is measured against the value of the proposed objectives. 
 
5.1 Model Modifications 
The following modifications were made to enhance the model predictions: 
 
5.1.1 Implementing O2 Mass Balance Equations 
The primary model (35) has been enhanced and modified in many aspects. CO 
impairs O2 delivery to the tissues, so the primary issue is to predict impairment of O2 
delivery in the presence of CO and its effect on tissue PO2. At the same time, the 
extravascular burden of CO depends on the O2 levels of the tissue. That is, the CO - 
O2 interaction involves a feedback loop, making it difficult to calculate the deliveries 
of O2 and CO unless the O2 mass balance equations are included. Thus to predict the 
CO load delivered, it is important to understand O2 availability (PO2) in the tissue. 
Hence mass balance equations for O2 were added for all compartments of the model. 
In the initial model O2 parameters were passed as constants, while in the current 
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model all O2 parameters are calculated within the model. They are determined by 
solving simultaneous algebraic equations for oxyhemoglobin dissociation curves, and 
integrating the differential mass balance equations as described in Section 3.8 of 
chapter 3. We know that impaired O2 delivery (CO hypoxia, hypoxic hypoxia, 
increased demand for oxygen while performing high stress exercise), and insufficient 
O2 availability (coronary artery diseases, occlusion and ischemia) can disturb the 
homeostasis of energy metabolism (ATP production), blood flow and O2 pressure 
gradients. Incorporating O2 mass balance equations into the model has enhanced the 
ability of the model to predict O2 tensions (which are difficult to measure 
experimentally) in the cardiac compartment and extended its application to simulate 
hypoxia, exercise and other conditions resulting in O2 insufficiency.  
 
5.1.2 Model Architecture and Flow Design 
 Modifying the model design to incorporate two subcompartments instead of a 
single compartment to represent the heart and the skeletal muscle helped in 
addressing the limitations related to O2/CO diffusion and arterio-venous shunting, and 
the well-known fact that PO2 is not the same throughout a tissue. Maintaining the 
balance of the O2 supply and demand is very important in determining tissue oxygen 
tension.  Attributing the skeletal muscle with regional flow and metabolic demand has 
allowed a better prediction of O2 tension and CO load. Blood to tissue oxygen flux 
equations (Section 2.1.3, chapter 1) were modified by estimating them as a function 
of pressure gradients and the diffusion coefficient of O2 (Section 3.2.2, chapter 3) 
instead of making an assumption of equality between O2 flux and metabolic demand 
of the compartment (35).  Also, in the current model, the nonlinear changes in O2 and 
CO are being better accounted for due to improved algorithms (Section 3.8, chapter 
3).  I also implemented a new algorithm to solve the simultaneous algebraic equations 
to calculate the partial pressure of O2 corresponding to the concentration of oxygen 
halfway between the inlet and outlet of the vascular subcompartment of the tissue 
(Section 3.8, chapter 3). 
Adding a Cardiac Compartment to the Model: A two-subcompartment cardiac 
compartment was added to the model which is one of the main goals of the thesis. 
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The skeletal and cardiac muscle exhibit major differences in anatomy, blood flow, 
and O2 demand.  Unlike skeletal muscle, cardiac muscle works constantly to pump 
blood and it would, therefore, be inappropriate to lump the cardiac muscle with the 
resting skeletal muscle. Implementing a cardiac compartment made noninvasive 
predictions of MbCO levels and oxygen tension in the tissues possible. These values 
are difficult to measure experimentally (noninvasivly) in the human heart.  
 
5.1.3 Physiological Relevance 
Regulation of cardiac output with respect to increased blood HbCO 
(carboxyhemoglobin) levels was implemented into the model by means of a 
predictive equation (68, 69, 70). Blood volume was estimated for individual subjects 
by means of a regression equation reported in the literature (78). Estimating 
myocardial O2 consumption and myocardial blood flow as a function of heart rate 
(increases in heart rate would increase the work load of the heart resulting in higher 
O2 demand and increased O2 supply to meet the increased O2 demand) helps in 
calculating estimates close to physiological values with increased heart rate. 
Permeability surface area product increases linearly with increases in blood flow, 
contributing to efficient diffusion of O2 in times of O2 impairment; this phenomenon 
was also added to the model. 
 
Model application: Applying these modifications has enhanced the capability of 
the model to make predictions of tissue oxygen tension in the human heart during 
hypoxic hypoxia, exercise, higher altitude and other O2 insufficiency conditions. 
 
5.2 Model Limitations  
The foremost limitation of the model is that it has lumped component 
parameters causing aggregation errors. This results in loss of anatomic resolution and 
functional representation of the organ, such as in the case of cardiac component layers 
of the heart (epicardium, midmyocardium, endocardium) and chambers of the heart 
(atria and ventricles) which display varied heterogeneity in blood flow, O2 
consumption, capillary density and tissue volume. But if one had to model the cardiac 
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muscle tissue for the purpose of this thesis, the best choice to model would be  the 
region of left ventricular mid myocardium, as this region is especially susceptible to 
injury during CO exposure due to its high O2 demand and the fact that CO 
interferences cause  impairment of O2 delivery. The heart is a dual pump, the left and 
right sides of the heart pump blood separately, but simultaneously, into the systemic 
and pulmonary systems. In order to pump blood efficiently, it is required for the right 
and left atria to contract first followed immediately by contraction of the right or left 
ventricle, respectively. Spreading of action potentials from one myocyte to other and 
depolarization of the plasma membrane triggers contraction of the cardiac muscle. 
Thus, mismatch of O2 supply and demand in the most susceptible left ventricular 
myocardial region may cause alterations in myocyte functionality (spreading of action 
potential) in this region, resulting in disruption of synchronous functionality 
(sequence of excitation) of the heart leading to arrhythmia. Thus, most of the 
predictive equations for determining the blood flow and O2 consumption were built 
for the left ventricular region (left ventricle and intraventricular septum) of the heart. 
When the model was tested using experimentally measured values of regional 
myocardial blood flow and O2 consumption as inputs, model predictions of 
experimental coronary venous PO2 were able to match the experimental values 
obtained as seen from Figure 4.1 of chapter 4. However, limitations due to diffusion 
and capillary heterogeneity were overcome to an extent by implementing two 
subcompartments. This allowed intertissue diffusion of O2 and CO.  Also, using two 
subcompartments allowed indirect arterio-venous O2 and CO shunting within the 
tissue. However, the design for incorporating two subcompartments instead of a 
single compartment raises issues regarding the maximum number of 
subcompartments that can be implemented. This concern must be considered in 
relation to the thesis objective of predicting injury to the heart due to CO exposure. 
Our main concern here is to model the CO uptake by the blood and the cardiac tissue. 
We are basically predicting the average MbCO and PO2 levels of the tissue by means 
of the model. Thus by distributing cardiac muscle into two compartments, we assume 
that the first compartment is the tissue perfused with small arterioles and small 
venules, as well as by capillaries, and the second compartment is perfused by 
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capillaries. By making this assumption, we are making an attempt to understand the 
behavior of tissue with respect to its distance from a capillary, arteriole or venule 
during CO hypoxia. The MbCO levels and tissue PO2 in the first compartment would 
reflect experimental measurements of values made near an arteriole while the second 
compartment predictions would be comparable to measurements made in the tissue 
close to a capillary. Also, one has to make a trade off between computational expense 
and achieved numerical accuracy in model predictions. Thus, considering all these 
issues, the two subcompartment cardiac model seems to be a reasonable compromise. 
Another limitation of the model is that it does not incorporate details of 
metabolic pathways (change from aerobic to anaerobic metabolism), coupling with 
electro-physiological events (action potential due to K+, Na+ Ca2+ channels) 
regulating coronary venous PO2 (156) and biochemical events (Pcr, pH). The human 
heart, being a complex system, has many other backup regulation modules to restore 
homeostasis during conditions of diminished O2 availability such as CO exposure or 
increase in O2 demand as in exercise. Regulation of cardiac output and heart rate was 
implemented into the model by adding predictive equations to estimate variations in 
both cardiac output and heart rate as functions of blood HbCO levels. The effect of 
vasodilatation and capillary recruitment on blood-tissue gas exchange was 
implemented by increasing the permeability surface area product (PScm) as a linear 
function of increases in blood flow to the heart. Apart from increases in cardiac 
output, HR and vasodilatation which are implemented into the model, there are other 
functional mechanisms taking place like the change of metabolic pathways from 
aerobic cycle to anaerobic cycle due to diminished O2 levels in tissue, variation in 
blood pressure, etc. Also, the role of myoglobin facilitated diffusion and cytochrome 
C oxidase interactions with CO is not clear (130,150). Gutierrez (1986), Waller et al., 
(1988), Forster (1970), Holland (1970), Roughton (1964), Sharan et al., (1990) , 
Corpes et al., (1989) have  shown the dependence of rate of CO uptake by blood on a 
series of chemical reactions of O2 and CO in the blood (association and dissociation 
rate coefficients of O2  and CO with Hb), pH and PO2.  Representation of kinetics of 
O2 and CO with hemoglobin (Hb) in modeling O2 and CO transport in the blood 
flowing through pulmonary and systemic circulation is difficult as the order of 
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magnitude of association and dissociation rate coefficients of O2  and CO with Hb are 
unknown (Sharan et al.,1989). pH was found to have second order effect on CO 
uptake. The effects of PO2 were considered in models built by Benignus et al., Bruce 
et al. and also in the present model (by solving for the oxyhemoglobin dissociation 
curves for Hb and Mb (myoglobin), Haldane equation and blood to tissue O2 flux 
equations). 
 
5.3 Parameter Estimation Concerns 
Estimating the parameters for a model is a crucial issue. Models have several 
parameters, some of which may greatly impact the model behavior while other 
parameters may not affect the model behavior at all. The impact of the parameters on 
the model behavior becomes important when there is scarce or no data available for 
the parameters. In such cases sensitivity analysis is conducted for the parameters to 
determine their impact on model behavior. For the cardiac compartment in the model, 
average values from experimental data were considered for most of the parameters. 
Predictive equations were developed for estimating myocardial blood flow and 
oxygen consumption.  
Prediction formulas were also used to estimate cardiac output and heart rate 
when actual values were not available. Subject variability is one major concern in 
using average values or prediction equations to estimate parameters. The estimates 
made for the parameters using predictive formulas would be valid for a specific group 
(age, ethnicity, gender, geographical area being at higher altitudes or below sea level, 
method of measurement) from which they were developed. Appling a prediction 
equation or an average value obtained from a specific subject group to a varied 
population set may tend to underestimate or overestimate the model predictions. 
However, after developing these formulas, their statistical significance and validity 
were tested for data which were not used for developing the relationships (Section 
3.5, chapter 3). For predicting the myocardial O2 consumption and myocardial blood 
flow, a more reliable prediction could have been made by calculating the estimates 
from heart rate-blood pressure product. But blood pressure was unavailable for many 
databases we planned to simulate although heart rate was a parameter which was 
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readily available and can also be calculated from total body metabolic rate.  But no 
such relationship could be applied to estimate blood pressure as it is a greatly varying 
physiological parameter. Predicting myocardial O2 consumption and blood flow as 
functions of cardiac output seems to be an alternative estimation approach, but 
information supporting functional relations between cardiac output, myocardial O2 
consumption and blood flow is currently unavailable in the literature.  
Estimating a value for resting permeability surface area product for the two 
cardiac subcompartments was very difficult due to unavailability of data. The initial 
guess values were obtained from models from Beard and Bassinghwaite and then the 
resting values were scaled to match the size of the tissue, type of the tissue, and the 
species. The permeability surface area products increased as a linear function of 
blood flow. This was to indirectly implement coronary vasodilatation and capillary 
recruitment into the model. 
The values for distribution of volume in each of the compartments (Fvcm) and 
for the fraction of venous cardiac blood compartment 3 perfusing the tissue 
compartment 1 was estimated by analyzing data available on vascular distribution in 
heart, coronary physiology, and statistics on density of arterioles, capillaries and 
venules in the heart (103,104). The sensitivity analysis of these parameters is shown 
in table 3.8 of chapter 3, so that one can estimate the deviations in the predicted 
model values for variation in the parameters (to which model predictions are 
sensitive). 
 
5.4 Model Validation Concerns 
The major concern in validating the model was unavailability of human data for 
testing the model predictions. Animal data, however, were available for model 
validation. Data are shown in table 4.1.  One can see from the table the extent of 
variability and heterogeneity in the data available. Though data for dogs, swine and 
rats were available, the experimental values obtained from experiments involving 
swine were emphasized due to the similarity with human coronary anatomy and 
vasculature. Also, most of the data available are from anesthetized animals. Type of 
anesthesia used in the experiment can have a significant effect on the experimental 
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values measured (96). Another issue related to the experimental data available is the 
method of measurement. Most of the methods available for measuring myocardial 
tissue O2 tension are invasive. Reported values may have 10- 15% error due to the 
measurement electrodes consuming O2, errors due to diffusion of oxygen from blood 
or tissue to the electrode, shift in electrode position due to beating of the heart etc. 
Also insertion of the some electrodes (like needle electrodes) causes damage to tissue 
and cells and bleeding, thereby possibly contaminating the measured values. From the 
Figures 4.1-4.3 shown in chapter 4, it can be seen that coronary venous PO2 and 
compartmental tissue PO2 model predictions are close to the experimental values. 
Also, the predicted myocardial tissue PO2’s are in agreement with other models (95, 
101,104) that utilized a single heart compartment or a distributed (finite-element) 
model. 
 
5.5 Concerns Related to Simulated Experiments  
 In this model heart rate is required to estimate myocardial O2 consumption and 
blood flow. In the experimental data provided by Benignus et. al and  Burge & 
Skinner, heart rate information is unavailable. Heart rate might have been estimated 
by using the regression equation described in Section 3.5.3 of chapter 3, where heart 
rate is calculated as a function of total body O2 consumption. But total body O2 
consumption was not measured by the investigators (Benignus et. al and  Burge & 
Skinner), thus heart rate for simulations in Section 4.2.1- 4.2.3 was estimated using an 
average metabolic rate of 0.0032 ml/gm/min. Total body O2 consumption, heart rate,  
myocardial O2 consumption and blood flow estimated in the model may differ from 
actual values at the time of experiments. Errors in estimation of the above parameters, 
especially heart rate, may have significant effects on the model predictions. For 
simulations having exercise sessions (Section 4.2.4), CO diffusion coefficient of 
lungs (DLCO), shunt fraction SF are assumed to be constants. Zavorsky et al. (2004), 
Demirjian (1980) and Paoletti (1985) have reported age dependent changes in DLCO 
with varying exercise intensity. Also the shunt fraction is reported to increase with 
increases in exercise intensity (159, 160). 
 
 110
5.6 Simulation Findings 
In all the simulations of Section 4.2, except for the simulation in Section 4.2.3 (where 
the subject rebreathes CO during 100% O2), the MbCO levels of cardiac 
subcompartment 2 (MbCOcm2) are higher than the MbCO levels in subcompartment 
1 (MbCOcm1). Higher MbCO levels in subcompartment 2 may be explained as 
follows: when CO is inhaled, it diffuses through the lung and binds with Hb in blood, 
resulting in elevated HbCO levels. CO then leaves blood and diffuses into the cardiac 
subcompartment 1, resulting in increased MbCO levels in the compartment initially. 
CO then diffuses into subcompartment 2 from the blood subcompartment 2 and also 
from the tissue subcompartment 1, thereby resulting in higher MbCO levels in 
subcompartment 2. Also, with increase in blood HbCO levels the cardiac output 
increases. Increased cardiac output would result in increased myocardial O2 
consumption and myocardial blood flow. This means that CO delivery to the heart 
increases with increase in cardiac blood flow, resulting in increased myocardial O2 
consumption and fall in tissue PO2, facilitating an increase in MbCO. This effect is 
more significant in the subcompartment 2 as the amount of CO delivered, blood flow 
and metabolic rate of this subcompartment is greater than subcompartment 1 resulting 
in lower tissue PO2 and higher MbCO levels. In the case of the simulation of CO 
rebreathing during 100% O2, the MbCO levels in the two subcompartments reach 
equilibrium after few minutes as seen in Figure 4.7 of chapter 4. The HbCO and 
MbCO levels are 10% and 4.5%, respectively, and the PO2 in the cardiac 
subcompartments decreases by ~1-2 Torr from base line. The reason for the heart 
compartments not being hypoxic during CO rebreathing is that the subject is 
breathing 100% O2. During hyperoxia, dissolved O2 plays a major role in tissue 
oxygenation. At the end of the simulation although the subject breaths 100% O2, a 
significant increase in PO2 of cardiac subcompartment 2 is not seen. 
 Another interesting observation in all the simulations discussed in Section 4.4.4 is 
that the MbCO levels of the two tissue subcompartments increase with exercise, 
though the HbCO levels are maintained constant. This means that increase in exercise 
increases the CO load on heart due to increased blood flow. Also, increased intensity 
of exercise causes a rise in O2 consumption, requiring higher O2 demand, thus 
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resulting in tissue hypoxia.  This observation also supports the reported observations 
of a higher risk of cardiac injury in a working population exposed to CO.  
 The developed model is capable of predicting myocardial tissue and blood PO2 
during all transients (different exercise sessions at different HbCO levels, long and 
short CO exposures etc) in the simulations. However, tissue PO2 in cardiac 
subcompartment 2 being maintained at 19 torr during hyperoxia (administration of 
100% O2 after 3 graded levels of exercise with 20% HbCO) after 60 min of breathing 
100% O2 seems to be a concern. Prediction of lower PO2 during hyperoxia may be 
due to the following reason: insufficient treatment time (simulation can be done by 
increasing the treatment time from 60 mins to 300-400 mins and see if the PO2 in 
subcompartment 2 increases), or due to errors in model parameters in the treatment 
protocol (as parameters were not measured by the investigators). 
 Decreases in coronary venous PO2 with increased exercise intensity have been 
reported (156). The cardiac compartment venous PO2 decreases with exercise as seen 
from Figure 4.5. However changes in coronary venous PO2 during combined exercise 
and CO exposure have not been reported in human or swine in the current literature. 
Thus validating the simulation results becomes difficult. Tissue PO2 of 6-7 Torr have 
been reported in mild exercising skeletal muscle tissue of humans whose steady state 
resting values at baseline HbCO levels are 35 Torr (158). An average myocardial 
tissue PO2 of 3.36 Torr at the end of third stage of moderate exercise (E3) at 20% 
HbCO levels seems reasonable. Prediction of tissue PO2 by the model in the range of 
0.5-1 Torr for a time span of 8-9 mins may be considered lethal (75,130,132,133). 
The model can be validated further if experimentally measured data for myocardial 
blood and tissue PO2 would be available in humans or swine during CO exposures at 
rest, exercise, hyperoxia and O2 hypoxia. 
 
   As seen in Figure 4.5 there is a sharp increase in the MbCO levels of the cardiac 
compartments with increase in HbCO levels of the blood, whereas the MbCO levels 
of the skeletal muscle increase gradually after the HbCO blood levels decrease. This 
sharp immediate increase in MbCO levels suggest that the CO released from 
hemoglobin binds to the myoglobin present in the cardiac muscle. Also the cardiac 
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tissue PO2 decreases with increases in HbCO and MbCO levels, suggesting greater 
risk of injury than skeletal muscle. The cardiac muscle has higher O2 consumption, 
blood flow and capillary density than that of resting skeletal muscle and 
unavailability of O2 store would result in greater degree of hypoxia. As seen in Figure 
4.6, during long-low CO exposure the MbCO levels of the cardiac compartment 
increase with increase in HbCO levels and after a certain amount of time exceed 
HbCO levels in the blood, suggesting that myocardial tissue hypoxia is the 
combination of impaired O2 carrying capacity of blood and impaired O2 storage in 
myoglobin. Thus one can confirm that the response of various tissue to CO exposure 
is different, based on their functionality and oxygen consumption. Thus it would not 
be valid to apply the same response to all the tissues.  
 
The hypothesis tested for the thesis was that during CO exposures and subsequent 
therapies, the temporal changes of %MbCO in the heart differ from those of %HbCO 
was tested. From the various simulations, it was found that HbCO and MbCO levels 
in the heart greatly depend on the type of CO exposure. In the case of short-high CO 
exposures, the MbCO levels positively correlate with HbCO, while in long-low CO 
exposures, the MbCO levels increase with increasing HbCO initially but later increase 
to levels higher than blood HbCO levels. During exercise though the HbCO levels are 
constant, the MbCO levels increase resulting in decreased tissue oxygen tensions. 
Thus, the results obtained support the hypothesis made. The CO load is related to 
both %HbCO in arterial blood perfusing the heart and %MbCO in cardiac tissue. In 
long-low CO exposures myocardial hypoxia occurs due to impaired O2 transport 
(decrease in %HbO2) and unavailability of O2 storage (%MbO2) where as in short-
high CO exposures, tissue hypoxia is mainly due to impaired O2 transport and in 
exercise protocols the cardiac hypoxia is mainly due to unavailability of O2 storage 
(%MbCO). Thus basing the treatment on the currently-used clinical indicator of 
potential injury (i.e., %HbCO) will be inaccurate and possibly misleading.  Thus, 
determining the total CO load on the cardiac cells (or its effect on tissue PO2) is likely 
to be a better predictor of injury.  
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Overall, the developed model proves to be an excellent tool for predicting 
extravascular burden (MbCO levels and tissue PO2) of CO on human heart.  
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CHAPTER 6 
Conclusion  
 
Noninvasive measurement of myocardial tissue PtO2 and MbCO levels during or after 
CO exposure is difficult. The main goal of the thesis was to develop a model that is 
capable of predicting extravascular burden of CO in the human heart and its effects 
on tissue oxygenation. A multi compartment model was developed consisting of six 
major compartments: 1.The arterial blood, 2. The Lungs, 3. Skeletal Muscle with two 
subcompartments, 4. Non-muscle tissue, 5. Cardiac Muscle with two 
subcompartments and 6. Mixed venous blood compartments. Mass balance equations 
are written for O2 and CO for each of these compartments. In each blood 
compartment, to determine PO2, PCO and O2 flux we solve three simultaneous 
algebraic equations: the oxyhemoglobin dissociation curve, Haldane’s equation, and 
the blood-to-tissue flux equation for oxygen. Myocardial blood flow and oxygen 
consumption are estimated from regression equations developed for the thesis. The 
model is simulated on a Windows XP system using ACSL™ software which is 
capable of solving nonlinear differential equations. Sensitivity analysis is performed 
and the myocardial tissue PO2 (PtO2) is shown to be sensitive to myocardial blood 
flow, myocardial oxygen consumption, volume distribution fraction of the tissue, 
diffusion coefficient of O2 and the permeability surface area product. The developed 
model was used for the simulations to test the validity of the predicted variables of 
the cardiac compartment with published observations on human subjects and 
anesthetized animals.  The model was validated for conditions of normoxic rest, 
hypoxic rest, hypoxic exercise and hyperoxia with regard to its predictions of 
coronary venous PO2 and tissue PO2. Simulation of short-high concentration CO 
exposure, long-low concentration CO exposure, CO rebreathing during 100% O2 
administration and CO exposure during rest and exercise sessions for different levels 
of HbCO have been analyzed. In short-high concentration exposures, the tissue 
MbCO levels increase sharply unlike in long-low concentration exposures where the 
MbCO levels increase gradually. The tissue PO2 levels seem to be correlated more 
with %HbCO levels than with %MbCO levels in short-high CO exposures. This 
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would suggest that there is impaired O2 delivery to tissues due to impaired O2 
transport. During long-low CO exposures, the tissue PO2 correlates with MbCO 
levels i.e., it decreases with increase in MbCO. In the simulation where subject 
rebreathes CO during 100% O2 administration, the tissue PO2‘s correlate with 
%HbCO levels and %MbCO levels increase with corresponding decreases in %HbCO 
levels suggesting that during hyperoxia, CO dislodged from hemoglobin is taken up 
by myoglobin. During exercise, the tissue PO2‘s are strongly correlated with MbCO 
levels, suggesting that myocardial tissue hypoxia occurs during elevated levels of 
MbCO. Also,  during room air treatment the MbCO and HbCO levels fall slowly 
compared to treatment with 100% O2, indicating that 100% O2 can be an effective 
treatment for CO hypoxia in cardiac muscle. The hypothesis that CO load (%HbCO, 
%MbCO) delivered to the heart impairs oxygen delivery further affecting the tissue 
oxygen tension (PtO2). Thus during CO exposures and therapies, the temporal 
changes of %MbCO in the heart differ from those of  %HbCO depending on the type 
of exposure. %MbCO levels can increase when %HbCO is maintained constant 
(during exercise) or is decreasing (in case of hyperoxia treatment). This CO load is 
related to both %HbCO in arterial blood perfusing the heart and %MbCO in cardiac 
tissue.  The correlation of %HbCO, %MbCO and tissue PO2 should be clearly 
understood for different types of CO exposure to consider them as clinical indicators 
of potential injury. The  decreasing tissue PO2 in the cardiac muscle during short-high 
CO exposure correlates with  increasing %HbCO levels while the %MbCO of skeletal 
muscle shows a correlation with %HbCO after a delay. The %MbCO levels of the 
cardiac compartment show sharp increases unlike gradual increases as seen in skeletal 
muscle. This is a very important observation as it emphasizes the fact that cardiac 
muscle is at higher risk than resting skeletal muscle. During elevated %MbCO levels, 
the PO2 stores may diminish resulting in the tissue being further hypoxic. 
 The cardiac muscle is a rigorously working muscle with high metabolic demands 
for oxygen. Myoglobin provides the storage site for O2 in times of increased O2 
demand. During CO exposure the storage site of O2 is lost as CO binds to myoglobin, 
resulting in increased %MbCO levels and tissue oxygen deprivation, thus resulting in 
severe hypoxia. A tissue PO2 in the range of 0.5 to 1 Torr is assumed to be indicative 
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of injury. O2 is needed for the heart to maintain its functions and lack of O2 supply 
can cause severe injury to the tissue. Thus the risk of injury would be greater when 
someone is exercising and is exposed to CO. Also in a patient population with 
congestive heart failure or coronary artery disease where myocardial perfusion is not 
normal, exercise or exposure to CO may be fatal to the myocardial tissue.  
Thus, determining the CO load on the cardiac tissue seems to be an important 
predictor of injury. The model proves to be an effective tool for noninvasive 
determination of the MbCO levels and oxygen tensions in a human heart during and 
after CO exposure. 
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CHAPTER 7 
Future Work 
 
1) Compare CO dose to myocardium with occurrence of abnormal features in ECG 
(ElectroCardioGram). Myocardial hypoxia during CO exposures has been 
reported to produce changes in ECG (S-T segment elevation, QT dispersion, T 
wave changes). The extent to which the CO load (HbCO and MbCO levels) 
contributes to ECG alterations seen in CO poisoning victims is unknown. 
Assesing the correlations between the occurrence of predicted peak MbCO and 
HbCO levels with occurrence of abnormalities in ECG will aid in understanding 
the CO poisoning related increased risk of cardiac injury.  
2) Investigate effects of DcmCO (diffusion coefficient of CO for cardiac muscle)  in 
exercise. Determination of DcmCO is difficult. The time for blood-tissue 
equilibrium of partial pressure of CO is dependent on DcmCO. The rate of 
exchange of CO between tissues and blood is determined by the value of DcmCO, 
thus determining the values for this parameter is important. If a large value of 
DcmCO better explains data, it would imply that the equilibrium between tissue 
and blood occurs at a faster rate, but if a smaller value for DcmCO would better 
fit the data, then it would support the concept of slow equilibration between tissue 
and blood.  Understanding the effects of DcmCO during exercise will result in 
further understanding the value for DcmCO.  
3) Prediction of the extravascular burden for all subjects of references 69,154,155. 
Applying the model to predict extravasuclar burden and assessing the produced 
response for different types of CO exposure conditions and population will help in 
improving the validation of the model. Also, if the same kind of response is 
displayed by the subject population, then the result can be better trusted. By 
fitting the model to a number of individuals, we can determine the mean as well 
as the range of responses in the normal population. 
4) Implement changes in DLCO (diffusion coefficient of CO in lungs) and SF (shunt 
fraction) with exercise. Adding effects of changing DLCO and SF into the model 
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as function of exercise intensity, age, gender etc. will further enhance the 
accuracy of model predictions. 
5) Predict CO burden on different regions (epicardium, endocardium) and chambers 
of the heart. Knowing that the heart displays heterogeneity in blood flow, 
capillary density, oxygen consumption etc., it would be interesting to predict 
cardiac injury in various regions to determine the region at higher risk for injury 
with CO exposure. 
6) Conduct experiments in swine to measure myocardial O2 consumption, 
myocardial blood flow, heart rate, blood lactate levels, weight of the heart, 
multiple measurements of myocardial tissue PO2 in various regions of the heart, 
coronary venous PO2, myocardial arterial PO2 during rest, graded levels of 
exercise, hypoxic hypoxia and CO hypoxia in order to validate the model. There 
is scarce data available in the literature for efficiently validating the model. Thus, 
if one conducts an experiment and measures all the above parameters, then the 
model can be better validated and also determination of parameters like 
permeability surface area product etc., will be more reasonable. 
7) Design effective treatment protocols. As seen from the results, the CO load would 
differ with type (short-high, long-low or during exercise) of CO exposure, thus it 
would not be advisable to treat all the CO - poisoned victims with the same 
protocol. Using the model to simulate different treatment protocols that may 
include mixed session of room air, 100% O2 breathing or hyperbaric treatment to 
improve tissue oxygenation will be a effective approach for efficient treatment 
strategies. The model may use the CO victim’s parameters and simulate different 
treatment protocols, which would be quick and easy to accomplish unlike 
conducting clinical trials. 
8) Estimate concentration and duration of CO exposure after the fact. Knowing the 
concentration and time for which the victim was subjected to CO would better 
determine the load of CO on organs at high risk like heart and brain during 
exposure and treatment. If it is a short CO exposure at high concentrations, then 
myocardial hypoxia would be produced due to impaired O2 capacity of blood 
unlike in long-low CO concentration CO exposures, where tissue hypoxia is 
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produced due to impaired O2 transport accompanied with impaired O2 storage as 
hemoglobin as well as myoglobin are bound to CO. Thus, estimating 
concentration and duration of CO exposure would be very crucial in designing an 
effective treatment protocol.    .  
9) Implement equations for CO2 in to the model. During both exercise and hypoxic 
hypoxia, the tissue PO2 are dependent on the partial pressure of CO.. Thus 
implementing equation for CO2 into the model will enhance the model to better 
predict the tissue PO2 and also conditions of hypoxic hypoxia can be better 
predicted. Also the effects of pH can be implemented into the model. These 
additions will result in enhanced model predictions as the oxygen dissociation 
curve which is solved to determine tissue PO2 and PCO would be dependent on 
CO2 and pH. 
10) Modify the model to predict myocardial oxygen tension in patient population with 
coronary artery diseases etc. The model can also be used to predict myocardial O2 
tensions apart from using it for predicting MbCO and HbCO levels. Generally in 
patients with coronary artery diseases, there is decreased blood flow to the heart 
due to narrowed or blocked arteries. Thus the blood flow to the myocardium can 
be reduced depending on the degree of blockage and myocardial oxygen tensions 
can be predicted. Also, conditions of exercise can be simulated for this population 
and the predicted myocardial tissue PO2‘s can be correlated with abnormalities in 
ECG. 
11) The model can also be modified for predicting outcomes of hyperbaric O2 
treatment. It is often debated if hyperbaric (breathing 100% O2 at 2-3 ATA) 
treatment would have better treatment outcomes than hyperoxia treatment 
(breathing 100% O2). 
12) Implementing metabolic pathways into the model may be suggested to understand 
the effects on model prediction with changes in metabolic cycles from aerobic to 
anerobic during exercise, hypoxia or ischemia. 
13) Introduce interactions of cytochrome c oxidase with CO. Cytochrome c oxidase is 
also known to bind irreversibly with CO. Understanding the contribution of this 
protein will further enhance the knowledge database for CO toxicity.  
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Appendix  
Skeletal muscle mass distributed to trunk muscle, leg muscle and arm muscle: 
Oxygen consumption for the skeletal muscle was found to be 250% of total body oxygen 
consumption at rest when calculated in the simulated model. According to the following 
books; 
1. An introduction to cardiovascular physiology by J.Rodney Levick 
2. Medical physiology by Philip Bard 
Muscle metabolic rate (MRO2m) should be 20% of the total body oxygen consumption 
(MRO2). It is known that metabolic rates of leg, arm and trunk muscles are different. 
Thus, to incorporate different metabolic rates of muscle in various regions we distributed 
the skeletal mass into three muscle volume compartments namely leg muscle volume, 
arm muscle volume and trunk muscle volume. Distributions of skeletal mass were 
calculated from the references 105-115. From the papers we had data for lean mass of 
trunk, arms, legs, upper legs, upper arms and also total skeletal mass. Data were entered 
only from normal men and women. The abbreviations used are as follows: 
%asm: percent arm skeletal mass 
%tsm: percent trunk skeletal mass 
%lsm: percent leg skeletal mass 
The final result obtained after taking average of data obtained : 
MEN:                                             WOMEN: 
                  
                                               
 
Validation for the relationship obtained was done by selecting a random subject record 
from the database and calculating the values using the obtained relationship and 
comparing them with the measured values. The differences in the values can be explained 
as follows: 
1. Total lean soft tissue included muscle as well as soft tissue 
2. Reference involved study on Japanese subjects in the age group of 19-24yrs. We 
know that muscle mass is effected with age and also ethnicity. 
%lsm %asm %tsm 
46.63981 15.66698 37.76795
%lsm %asm %tsm 
49.52738 13.96499 36.50763 
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3. Also one can consider errors due to averaging, pooling data from various sources 
which have different methods of measurement, varying number of subjects, 
different age population, ethnicity etc. 
 
gender Men  (total lean soft tissue= 
57.8kg) 
Women (total lean soft tissue= 
40kg) 
parameter lsm asm tsm lsm asm tsm 
measured 20.9 8.7 28.2 14.8 4.9 20.3 
calculated 26.9 9.05 21.82 19.8 5.58 14.6 
 
Prediction equation for cardiac output: 
Equation to predict the cardiac output in the initial model was based on  gender and body 
weight. GBWGQ .2001400).9.71.54( . −++=  
But after modifying the model, we intended to simulate experiments that involved 
exercise, CO exposure etc. It was clear that cardiac output Q۠ changed with exercise, 
postural changes and age. Thus to implement variation of cardiac output, we 
implemented the following prediction equation, 
Q˙ =3.186+7.346* (MRO2)-0.535*(MRO2)2 
Where, cardiac output Q˙ is calculated as a quadratic expression function of total body 
metabolic rate (MRO2). Also this equation was very helpful in predicting the cardiac 
output when experimental data did not provide the value. Literature survey established 
the fact that cardiac output can best be predicted as a function of total body oxygen 
consumption (references). Thus, to work on this idea, various journals were searched for 
data from humans at rest and exercise for cardiac output and total body oxygen 
consumption (MRO2).The inclusive criterion for the data was that it was considered from 
healthy, non smoking untrained individual subjects. The method of measurement for 
MRO2 was either Fick’s method or the Douglas bag method. Cardiac output was 
calculated from dye dilution method, Fick’s method etc. Though the measurement 
techniques were different, the values obtained for cardiac output for specific oxygen body 
consumption did not vary significantly. Data from references 137-144 were used to 
implement the relationship. The reason for building a quadratic expression was to have a 
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regression relation with strong statistical significance and also cardiac output is known to 
reach a plateau as maximal body oxygen consumption is reached. 
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Figure above shows the plot of the data (o) used to build the relationship and predicted 
data (*). On the X-axis we have the myocardial O2 consumption and on the Y-axis is the 
cardiac output. Test data points (o,o) were considered from experiments whose data were 
not included in building the relation to check with the values(*,*) obtained from the 
predictor equation. Cardiac output (Q˙)  and myocardial oxygen consumption (MRO2) are 
specified and calculated in the unit of liter/min. When implemented into the model they 
are converted into milliliter. MRO2 is in STPD and is converted to BTPS in the model.  
 
Order of relation Regression coefficient  Error of estimate 
Q• = b.MRO2 +c 0.907 1.949 
Q• = a.(MRO2)2+b.MRO2+ c 0.962 1.75 
 
Prediction equations for Heart rate: In most of the experiments, heart rate was 
mentioned. But in the case of data where information regarding heart rate was missing, it 
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was estimated from the following equation: Heart Rate (HR) =42.819+68.884*(MRO2)-
8.26* (MRO2)2 
 The main purpose for developing a prediction equation for heart rate was to estimate the 
myocardial blood flow and myocardial oxygen consumption for the cardiac compartment 
discussed in Chapter 3. Heart rate is often considered to be a predictor of extent of 
myocardial activity. Heart rate and blood pressure product would have been a better 
predictor of myocardial parameters like myocardial blood flow and oxygen consumption 
than just heart rate. But it was difficult to predict blood pressure from body oxygen 
consumption or cardiac output due to unavailability of sufficient data. Thus, heart rate 
was expressed as a function of MRO2.  The following references (68-70), were 
considered to obtain a relationship between heart rate (HR) and body oxygen 
consumption (MRO2). 
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Figure above shows the plot of the data (o) used to build the relationship and predicted 
data (*). On the X-axis we have the myocardial O2 consumption and on the Y-axis is the 
Heart rate. Test data points (o,o) were considered from experiments whose data was not 
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used to estimate the above regression relation to check with the values(*,*) obtained from 
the predictor equation. 
 
Order of relation Regression coefficient  Error of estimate 
HR = b.MRO2 +c 0.592 23.678 
HR = a.(MRO2)2+b.MRO2+ c 0.664 21.5 
 
Predicting percent increases in cardiac output (Q•) and heart rate (HR) as functions 
of percent carboxyhemoglobin (%∆ COHb) levels in blood:  
There is a reported increase in cardiac output and heart rate with increase in 
carboxyhemoglobin levels in blood (68, 69). While simulating experiments involving 
carbon monoxide (CO) exposures, increased cardiac output and heart rate due to 
increased carboxyhemoglobin levels in the blood  had to be taken into account. These 
increases were implemented by introducing the following equations 
 %∆Q• =0.572 x ( %∆COHb) 
 %∆HR =0.012 x (%∆COHb) 2 + 0.26 x (%∆COHb) 
The cardiac output Q˙ and heart rate (HR) were increased by %∆Q and %∆HR, 
respectively, calculated from the above equations in the discrete section of the program. 
Data for cardiac output, heart rate and carboxyhemoglobin (up to 50%) were tabulated 
from references 68,69. 
Linear regression was performed on the data. Outliers of the data were removed. 
Statistical significance of the relationships was tested and the best relation was chosen 
and implemented into the model to incorporate the changing effects in cardiac output and 
heart rate with increasing CO levels in the body. 
Cardiac output and Carboxyhemoglobin levels in blood: 
Order of relation Regression coefficient  Error estimate 
%∆Q• =a ( %∆COHb) + c 0.377 15.155 
%∆Q•=a(%∆COHb)2+b(%∆COHb)+c 0.178 15.184 
%∆Q• =a  ( %∆COHb) 0.713 12.483 
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Figure above shows the plot of the data (o) used to build the relationship and predicted 
data (*). On the X-axis we have the percent increase in carboxyhemoglobin levels of 
blood,  %∆COHb and on the Y-axis is the percent increase in cardiac output, %∆Q•.  
Cardiac output and Carboxyhemoglobin levels in blood: 
Figure below shows the plot of the data (o) used to build the relationship and predicted 
data (*). On the X-axis we have the percent increase in carboxyhemoglobin levels of 
blood,  %∆COHb and on the Y-axis is the percent increase in cardiac output, %∆HR. 
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Order of relation Regression coefficient  Error estimate 
%∆HR=a(%∆COHb)2+b(%∆COHb)+c 0.422 9.962 
%∆HR=a(%∆COHb)2 +c 0.422 9.961 
%∆HR=a(%∆COHb)2+b(%∆COHb) 0.612 9.958 
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